<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>2 Cerebrovascular | Vascular Surgery Exam Prep</title>
  <meta name="description" content="This is an ebook version of exam preparation content produced for Audible Bleeding: The Vascular Surgery Podcast, powered by the Society for Vascular Surgery" />
  <meta name="generator" content="bookdown 0.29 and GitBook 2.6.7" />

  <meta property="og:title" content="2 Cerebrovascular | Vascular Surgery Exam Prep" />
  <meta property="og:type" content="book" />
  
  <meta property="og:description" content="This is an ebook version of exam preparation content produced for Audible Bleeding: The Vascular Surgery Podcast, powered by the Society for Vascular Surgery" />
  <meta name="github-repo" content="https://github.com/adam-mdmph/VS-Exam-Prep" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="2 Cerebrovascular | Vascular Surgery Exam Prep" />
  
  <meta name="twitter:description" content="This is an ebook version of exam preparation content produced for Audible Bleeding: The Vascular Surgery Podcast, powered by the Society for Vascular Surgery" />
  

<meta name="author" content="Editors: Adam Johnson, MD, MPH; Matt Smith, MD, PhD; and Audible Bleeding" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="152x152" href="images/apple_icon.png" />
  
<link rel="prev" href="index.html"/>
<link rel="next" href="upper-extremity-and-thoracic-outlet.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">VS Exam Prep</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> About</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#usage"><i class="fa fa-check"></i><b>1.1</b> Usage</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#comments-questions-or-contributions"><i class="fa fa-check"></i><b>1.2</b> Comments, Questions or Contributions</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="cerebrovascular.html"><a href="cerebrovascular.html"><i class="fa fa-check"></i><b>2</b> Cerebrovascular</a>
<ul>
<li class="chapter" data-level="2.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#available-guidelines"><i class="fa fa-check"></i><b>2.1</b> Available Guidelines</a></li>
<li class="chapter" data-level="2.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#presentation-and-diagnosis"><i class="fa fa-check"></i><b>2.2</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="2.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management"><i class="fa fa-check"></i><b>2.3</b> Management</a>
<ul>
<li class="chapter" data-level="2.3.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#medical-management---asymptomatic-patients"><i class="fa fa-check"></i><b>2.3.1</b> Medical Management - Asymptomatic Patients</a></li>
<li class="chapter" data-level="2.3.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#medical-management---symptomatic-patients"><i class="fa fa-check"></i><b>2.3.2</b> Medical Management - Symptomatic Patients</a></li>
<li class="chapter" data-level="2.3.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#surgery---carotid-endarterectomy"><i class="fa fa-check"></i><b>2.3.3</b> Surgery - Carotid Endarterectomy</a></li>
<li class="chapter" data-level="2.3.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#endovascular---carotid-artery-stenting"><i class="fa fa-check"></i><b>2.3.4</b> Endovascular - Carotid Artery Stenting</a></li>
<li class="chapter" data-level="2.3.5" data-path="cerebrovascular.html"><a href="cerebrovascular.html#summary-of-prospective-trials"><i class="fa fa-check"></i><b>2.3.5</b> Summary of Prospective Trials</a></li>
</ul></li>
<li class="chapter" data-level="2.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#uncommon-carotid-disease"><i class="fa fa-check"></i><b>2.4</b> Uncommon Carotid Disease</a>
<ul>
<li class="chapter" data-level="2.4.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#complicated-extracranial-occlusive-disease"><i class="fa fa-check"></i><b>2.4.1</b> Complicated Extracranial Occlusive Disease</a></li>
<li class="chapter" data-level="2.4.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#vertebrobasilar-disease"><i class="fa fa-check"></i><b>2.4.2</b> Vertebrobasilar Disease</a></li>
<li class="chapter" data-level="2.4.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-artery-dissection"><i class="fa fa-check"></i><b>2.4.3</b> Carotid artery dissection</a></li>
<li class="chapter" data-level="2.4.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#internal-carotid-artery-aneurysms"><i class="fa fa-check"></i><b>2.4.4</b> Internal Carotid Artery Aneurysms</a></li>
<li class="chapter" data-level="2.4.5" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-body-tumors-cbt"><i class="fa fa-check"></i><b>2.4.5</b> Carotid Body Tumors (CBT)</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html"><i class="fa fa-check"></i><b>3</b> Upper Extremity and Thoracic Outlet</a>
<ul>
<li class="chapter" data-level="3.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#overview-of-upper-extremity-disease"><i class="fa fa-check"></i><b>3.1</b> Overview of Upper Extremity Disease</a>
<ul>
<li class="chapter" data-level="3.1.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy"><i class="fa fa-check"></i><b>3.1.1</b> Anatomy</a></li>
<li class="chapter" data-level="3.1.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#epidemiology-etiology-and-diagnostic-evaluation"><i class="fa fa-check"></i><b>3.1.2</b> Epidemiology, Etiology, and Diagnostic Evaluation</a></li>
<li class="chapter" data-level="3.1.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#evaluation"><i class="fa fa-check"></i><b>3.1.3</b> Evaluation</a></li>
</ul></li>
<li class="chapter" data-level="3.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vaso-occlusive-disease"><i class="fa fa-check"></i><b>3.2</b> Vaso-occlusive Disease</a>
<ul>
<li class="chapter" data-level="3.2.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#acute-limb-ischemia"><i class="fa fa-check"></i><b>3.2.1</b> Acute Limb Ischemia</a></li>
<li class="chapter" data-level="3.2.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#chronic-limb-threatening-ischemia"><i class="fa fa-check"></i><b>3.2.2</b> Chronic Limb Threatening Ischemia</a></li>
</ul></li>
<li class="chapter" data-level="3.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vasospastic-disorders"><i class="fa fa-check"></i><b>3.3</b> Vasospastic Disorders</a>
<ul>
<li class="chapter" data-level="3.3.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#iatrogenic-or-vasopressor-induced-ischemia"><i class="fa fa-check"></i><b>3.3.1</b> Iatrogenic or Vasopressor Induced Ischemia</a></li>
<li class="chapter" data-level="3.3.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#raynauds-phenomenon"><i class="fa fa-check"></i><b>3.3.2</b> Raynaud’s Phenomenon</a></li>
<li class="chapter" data-level="3.3.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ergotism"><i class="fa fa-check"></i><b>3.3.3</b> Ergotism</a></li>
<li class="chapter" data-level="3.3.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#buergers-disease"><i class="fa fa-check"></i><b>3.3.4</b> Buerger’s Disease</a></li>
<li class="chapter" data-level="3.3.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#large-vasculitis"><i class="fa fa-check"></i><b>3.3.5</b> Large Artery Vasculitis</a></li>
<li class="chapter" data-level="3.3.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#other-vasculitis-syndromes"><i class="fa fa-check"></i><b>3.3.6</b> Other Vasculitis syndromes</a></li>
</ul></li>
<li class="chapter" data-level="3.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#aneurysmal-disease"><i class="fa fa-check"></i><b>3.4</b> Aneurysmal Disease</a>
<ul>
<li class="chapter" data-level="3.4.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#subclavian-artery-aneurysms"><i class="fa fa-check"></i><b>3.4.1</b> Subclavian Artery Aneurysms</a></li>
<li class="chapter" data-level="3.4.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#axillary-artery-aneurysms"><i class="fa fa-check"></i><b>3.4.2</b> Axillary Artery Aneurysms</a></li>
<li class="chapter" data-level="3.4.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#brachial-artery-aneurysms"><i class="fa fa-check"></i><b>3.4.3</b> Brachial Artery Aneurysms</a></li>
<li class="chapter" data-level="3.4.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#radial-artery-pseudoaneurysm"><i class="fa fa-check"></i><b>3.4.4</b> Radial Artery Pseudoaneurysm</a></li>
</ul></li>
<li class="chapter" data-level="3.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#occupational-vascular-disease"><i class="fa fa-check"></i><b>3.5</b> Occupational Vascular Disease</a>
<ul>
<li class="chapter" data-level="3.5.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hand-arm-vibration-syndrome"><i class="fa fa-check"></i><b>3.5.1</b> Hand-Arm Vibration Syndrome</a></li>
<li class="chapter" data-level="3.5.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hypothenar-hammer-syndrome"><i class="fa fa-check"></i><b>3.5.2</b> Hypothenar hammer syndrome</a></li>
<li class="chapter" data-level="3.5.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#environmental-exposures"><i class="fa fa-check"></i><b>3.5.3</b> Environmental Exposures</a></li>
<li class="chapter" data-level="3.5.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#sports-medicine"><i class="fa fa-check"></i><b>3.5.4</b> Sports Medicine</a></li>
</ul></li>
<li class="chapter" data-level="3.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vascular-trauma-upper-extremity"><i class="fa fa-check"></i><b>3.6</b> Vascular Trauma-Upper Extremity</a>
<ul>
<li class="chapter" data-level="3.6.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#subclavian-artery-trauma"><i class="fa fa-check"></i><b>3.6.1</b> Subclavian Artery Trauma</a></li>
<li class="chapter" data-level="3.6.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#axillary-artery-trauma"><i class="fa fa-check"></i><b>3.6.2</b> Axillary Artery Trauma</a></li>
<li class="chapter" data-level="3.6.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#brachial-artery-trauma"><i class="fa fa-check"></i><b>3.6.3</b> Brachial Artery Trauma</a></li>
<li class="chapter" data-level="3.6.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#radialulnar-artery-trauma"><i class="fa fa-check"></i><b>3.6.4</b> Radial/ulnar artery trauma</a></li>
</ul></li>
<li class="chapter" data-level="3.7" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#compression-syndromes"><i class="fa fa-check"></i><b>3.7</b> Compression Syndromes</a>
<ul>
<li class="chapter" data-level="3.7.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#quadrilateral-space-syndrome"><i class="fa fa-check"></i><b>3.7.1</b> Quadrilateral space syndrome</a></li>
<li class="chapter" data-level="3.7.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#humeral-head-compression-of-axillary-artery"><i class="fa fa-check"></i><b>3.7.2</b> Humeral head compression of axillary artery</a></li>
</ul></li>
<li class="chapter" data-level="3.8" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#thoracic-outlet-syndrome"><i class="fa fa-check"></i><b>3.8</b> Thoracic Outlet Syndrome</a>
<ul>
<li class="chapter" data-level="3.8.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy-1"><i class="fa fa-check"></i><b>3.8.1</b> Anatomy</a></li>
<li class="chapter" data-level="3.8.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#presentation-5"><i class="fa fa-check"></i><b>3.8.2</b> Presentation</a></li>
<li class="chapter" data-level="3.8.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#evaluation-9"><i class="fa fa-check"></i><b>3.8.3</b> Evaluation</a></li>
<li class="chapter" data-level="3.8.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#management-10"><i class="fa fa-check"></i><b>3.8.4</b> Management</a></li>
<li class="chapter" data-level="3.8.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vtos"><i class="fa fa-check"></i><b>3.8.5</b> vTOS</a></li>
<li class="chapter" data-level="3.8.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#atos"><i class="fa fa-check"></i><b>3.8.6</b> aTOS</a></li>
<li class="chapter" data-level="3.8.7" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ntos"><i class="fa fa-check"></i><b>3.8.7</b> nTOS</a></li>
</ul></li>
<li class="chapter" data-level="3.9" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#upper-extremity-lymphedema"><i class="fa fa-check"></i><b>3.9</b> Upper Extremity Lymphedema</a>
<ul>
<li class="chapter" data-level="3.9.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#etiology-8"><i class="fa fa-check"></i><b>3.9.1</b> Etiology</a></li>
<li class="chapter" data-level="3.9.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#management-14"><i class="fa fa-check"></i><b>3.9.2</b> Management</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="4" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html"><i class="fa fa-check"></i><b>4</b> Abdominal Aneurysms</a>
<ul>
<li class="chapter" data-level="4.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#pathogenesis-presentation-and-risk-factors"><i class="fa fa-check"></i><b>4.1</b> Pathogenesis, presentation and risk factors</a></li>
<li class="chapter" data-level="4.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#evaluation-and-diagnosis"><i class="fa fa-check"></i><b>4.2</b> Evaluation and Diagnosis</a>
<ul>
<li class="chapter" data-level="4.2.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#imaging"><i class="fa fa-check"></i><b>4.2.1</b> Imaging</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#management-15"><i class="fa fa-check"></i><b>4.3</b> Management</a>
<ul>
<li class="chapter" data-level="4.3.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#evar"><i class="fa fa-check"></i><b>4.3.1</b> EVAR</a></li>
<li class="chapter" data-level="4.3.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#open-repair"><i class="fa fa-check"></i><b>4.3.2</b> Open Repair</a></li>
<li class="chapter" data-level="4.3.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#ruptured-aneurysms"><i class="fa fa-check"></i><b>4.3.3</b> Ruptured Aneurysms</a></li>
</ul></li>
<li class="chapter" data-level="4.4" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#iliacperipheral-aneurysms"><i class="fa fa-check"></i><b>4.4</b> Iliac/Peripheral Aneurysms</a>
<ul>
<li class="chapter" data-level="4.4.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#demographics-2"><i class="fa fa-check"></i><b>4.4.1</b> Demographics</a></li>
<li class="chapter" data-level="4.4.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#presentation-9"><i class="fa fa-check"></i><b>4.4.2</b> Presentation</a></li>
<li class="chapter" data-level="4.4.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#management-16"><i class="fa fa-check"></i><b>4.4.3</b> Management</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html"><i class="fa fa-check"></i><b>5</b> Lower Extremity Occlusive Disease</a>
<ul>
<li class="chapter" data-level="5.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#pathophysiology"><i class="fa fa-check"></i><b>5.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="5.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#intermittent-claudication"><i class="fa fa-check"></i><b>5.2</b> Intermittent Claudication</a>
<ul>
<li class="chapter" data-level="5.2.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#history-clinical-examination"><i class="fa fa-check"></i><b>5.2.1</b> History / Clinical Examination</a></li>
<li class="chapter" data-level="5.2.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-17"><i class="fa fa-check"></i><b>5.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#chronic-limb-threatening-ischemia-1"><i class="fa fa-check"></i><b>5.3</b> Chronic Limb Threatening Ischemia</a>
<ul>
<li class="chapter" data-level="5.3.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#etiology-and-presentation"><i class="fa fa-check"></i><b>5.3.1</b> Etiology and Presentation</a></li>
<li class="chapter" data-level="5.3.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#evaluation-12"><i class="fa fa-check"></i><b>5.3.2</b> Evaluation</a></li>
<li class="chapter" data-level="5.3.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-18"><i class="fa fa-check"></i><b>5.3.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.4" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#acute-limb-ischemia-1"><i class="fa fa-check"></i><b>5.4</b> Acute Limb Ischemia</a>
<ul>
<li class="chapter" data-level="5.4.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#presentation-and-diagnosis-1"><i class="fa fa-check"></i><b>5.4.1</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="5.4.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-19"><i class="fa fa-check"></i><b>5.4.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.5" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#compartment-syndrome"><i class="fa fa-check"></i><b>5.5</b> Compartment Syndrome</a></li>
<li class="chapter" data-level="5.6" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#blue-toe-syndrome"><i class="fa fa-check"></i><b>5.6</b> Blue Toe Syndrome</a>
<ul>
<li class="chapter" data-level="5.6.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#etiology-and-presentation-1"><i class="fa fa-check"></i><b>5.6.1</b> Etiology and Presentation</a></li>
<li class="chapter" data-level="5.6.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#evaluation-13"><i class="fa fa-check"></i><b>5.6.2</b> Evaluation</a></li>
<li class="chapter" data-level="5.6.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-20"><i class="fa fa-check"></i><b>5.6.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.7" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#non-atheromatous-popliteal-artery-disease"><i class="fa fa-check"></i><b>5.7</b> Non-atheromatous Popliteal Artery Disease</a>
<ul>
<li class="chapter" data-level="5.7.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#popliteal-artery-entrapment-syndrome-paes"><i class="fa fa-check"></i><b>5.7.1</b> Popliteal Artery Entrapment Syndrome (PAES)</a></li>
<li class="chapter" data-level="5.7.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#cystic-adventitial-disease"><i class="fa fa-check"></i><b>5.7.2</b> Cystic Adventitial Disease</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html"><i class="fa fa-check"></i><b>6</b> Mesenteric Disease</a>
<ul>
<li class="chapter" data-level="6.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#acute-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.1</b> Acute Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.1.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-evaluation"><i class="fa fa-check"></i><b>6.1.1</b> Presentation and Evaluation</a></li>
<li class="chapter" data-level="6.1.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-23"><i class="fa fa-check"></i><b>6.1.2</b> Management</a></li>
<li class="chapter" data-level="6.1.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#other-etiologies"><i class="fa fa-check"></i><b>6.1.3</b> Other Etiologies</a></li>
</ul></li>
<li class="chapter" data-level="6.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#chronic-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.2</b> Chronic Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.2.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-evaluation-1"><i class="fa fa-check"></i><b>6.2.1</b> Presentation and Evaluation</a></li>
<li class="chapter" data-level="6.2.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-24"><i class="fa fa-check"></i><b>6.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="6.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#mesenteric-aneurysms"><i class="fa fa-check"></i><b>6.3</b> Mesenteric Aneurysms</a>
<ul>
<li class="chapter" data-level="6.3.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#sma-aneurysm"><i class="fa fa-check"></i><b>6.3.1</b> SMA Aneurysm</a></li>
<li class="chapter" data-level="6.3.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#splenic-aneurysm"><i class="fa fa-check"></i><b>6.3.2</b> Splenic Aneurysm</a></li>
</ul></li>
<li class="chapter" data-level="6.4" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#median-arcuate-ligament-syndrome-mals"><i class="fa fa-check"></i><b>6.4</b> Median Arcuate Ligament Syndrome (MALS)</a></li>
<li class="chapter" data-level="6.5" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#sma-syndrome"><i class="fa fa-check"></i><b>6.5</b> SMA Syndrome</a></li>
<li class="chapter" data-level="6.6" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#uterine-fibroids"><i class="fa fa-check"></i><b>6.6</b> Uterine Fibroids</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="renal.html"><a href="renal.html"><i class="fa fa-check"></i><b>7</b> Renal</a>
<ul>
<li class="chapter" data-level="7.1" data-path="renal.html"><a href="renal.html#pathophysiology-1"><i class="fa fa-check"></i><b>7.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="7.2" data-path="renal.html"><a href="renal.html#medical-management-and-evaluation"><i class="fa fa-check"></i><b>7.2</b> Medical Management and Evaluation</a></li>
<li class="chapter" data-level="7.3" data-path="renal.html"><a href="renal.html#operative-managment"><i class="fa fa-check"></i><b>7.3</b> Operative Managment</a>
<ul>
<li class="chapter" data-level="7.3.1" data-path="renal.html"><a href="renal.html#endovascular-therapy"><i class="fa fa-check"></i><b>7.3.1</b> Endovascular Therapy</a></li>
<li class="chapter" data-level="7.3.2" data-path="renal.html"><a href="renal.html#open-surgery"><i class="fa fa-check"></i><b>7.3.2</b> Open Surgery</a></li>
</ul></li>
<li class="chapter" data-level="7.4" data-path="renal.html"><a href="renal.html#fibromuscular-dysplasia-fmd"><i class="fa fa-check"></i><b>7.4</b> Fibromuscular Dysplasia (FMD)</a></li>
<li class="chapter" data-level="7.5" data-path="renal.html"><a href="renal.html#renal-artery-aneurysms"><i class="fa fa-check"></i><b>7.5</b> Renal Artery Aneurysms</a>
<ul>
<li class="chapter" data-level="7.5.1" data-path="renal.html"><a href="renal.html#demographics-3"><i class="fa fa-check"></i><b>7.5.1</b> Demographics</a></li>
<li class="chapter" data-level="7.5.2" data-path="renal.html"><a href="renal.html#anatomy-2"><i class="fa fa-check"></i><b>7.5.2</b> Anatomy</a></li>
<li class="chapter" data-level="7.5.3" data-path="renal.html"><a href="renal.html#presentation-10"><i class="fa fa-check"></i><b>7.5.3</b> Presentation</a></li>
<li class="chapter" data-level="7.5.4" data-path="renal.html"><a href="renal.html#management-25"><i class="fa fa-check"></i><b>7.5.4</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="7.6" data-path="renal.html"><a href="renal.html#renal-artery-dissection"><i class="fa fa-check"></i><b>7.6</b> Renal Artery Dissection</a></li>
<li class="chapter" data-level="7.7" data-path="renal.html"><a href="renal.html#renal-vein-thrombosis"><i class="fa fa-check"></i><b>7.7</b> Renal Vein Thrombosis</a>
<ul>
<li class="chapter" data-level="7.7.1" data-path="renal.html"><a href="renal.html#diagnosis"><i class="fa fa-check"></i><b>7.7.1</b> Diagnosis</a></li>
<li class="chapter" data-level="7.7.2" data-path="renal.html"><a href="renal.html#management-26"><i class="fa fa-check"></i><b>7.7.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="7.8" data-path="renal.html"><a href="renal.html#renal-arteriovenous-fistula"><i class="fa fa-check"></i><b>7.8</b> Renal Arteriovenous Fistula</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html"><i class="fa fa-check"></i><b>8</b> Thoracic Aorta</a>
<ul>
<li class="chapter" data-level="8.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortic-dissection"><i class="fa fa-check"></i><b>8.1</b> Aortic Dissection</a>
<ul>
<li class="chapter" data-level="8.1.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#demographics-4"><i class="fa fa-check"></i><b>8.1.1</b> Demographics</a></li>
<li class="chapter" data-level="8.1.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#evaluation-16"><i class="fa fa-check"></i><b>8.1.2</b> Evaluation</a></li>
<li class="chapter" data-level="8.1.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#management-27"><i class="fa fa-check"></i><b>8.1.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="8.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aneurysms---thoracic-and-thoracoabdominal"><i class="fa fa-check"></i><b>8.2</b> Aneurysms - Thoracic and Thoracoabdominal</a>
<ul>
<li class="chapter" data-level="8.2.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#anatomy-and-demographics"><i class="fa fa-check"></i><b>8.2.1</b> Anatomy and Demographics</a></li>
<li class="chapter" data-level="8.2.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#management-28"><i class="fa fa-check"></i><b>8.2.2</b> Management</a></li>
<li class="chapter" data-level="8.2.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#additional-resources"><i class="fa fa-check"></i><b>8.2.3</b> Additional Resources</a></li>
</ul></li>
<li class="chapter" data-level="8.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortopathies"><i class="fa fa-check"></i><b>8.3</b> Aortopathies</a>
<ul>
<li class="chapter" data-level="8.3.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#links"><i class="fa fa-check"></i><b>8.3.1</b> LINKS:</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="9" data-path="venous-disease.html"><a href="venous-disease.html"><i class="fa fa-check"></i><b>9</b> Venous Disease</a>
<ul>
<li class="chapter" data-level="9.1" data-path="venous-disease.html"><a href="venous-disease.html#chronic-venous-insufficiency"><i class="fa fa-check"></i><b>9.1</b> Chronic Venous Insufficiency</a>
<ul>
<li class="chapter" data-level="9.1.1" data-path="venous-disease.html"><a href="venous-disease.html#terminology-and-presentation"><i class="fa fa-check"></i><b>9.1.1</b> Terminology and Presentation</a></li>
<li class="chapter" data-level="9.1.2" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-17"><i class="fa fa-check"></i><b>9.1.2</b> Evaluation</a></li>
<li class="chapter" data-level="9.1.3" data-path="venous-disease.html"><a href="venous-disease.html#management-29"><i class="fa fa-check"></i><b>9.1.3</b> Management</a></li>
<li class="chapter" data-level="9.1.4" data-path="venous-disease.html"><a href="venous-disease.html#other-complications-of-superficial-venous-disease"><i class="fa fa-check"></i><b>9.1.4</b> Other Complications of Superficial Venous Disease</a></li>
</ul></li>
<li class="chapter" data-level="9.2" data-path="venous-disease.html"><a href="venous-disease.html#acute-thrombosis---deep-venous-thrombosis-dvt"><i class="fa fa-check"></i><b>9.2</b> Acute Thrombosis - Deep venous thrombosis (DVT)</a>
<ul>
<li class="chapter" data-level="9.2.1" data-path="venous-disease.html"><a href="venous-disease.html#physiology"><i class="fa fa-check"></i><b>9.2.1</b> Physiology</a></li>
<li class="chapter" data-level="9.2.2" data-path="venous-disease.html"><a href="venous-disease.html#etiology-10"><i class="fa fa-check"></i><b>9.2.2</b> Etiology</a></li>
<li class="chapter" data-level="9.2.3" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-18"><i class="fa fa-check"></i><b>9.2.3</b> Evaluation</a></li>
<li class="chapter" data-level="9.2.4" data-path="venous-disease.html"><a href="venous-disease.html#management-30"><i class="fa fa-check"></i><b>9.2.4</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="9.3" data-path="venous-disease.html"><a href="venous-disease.html#phlegmasia"><i class="fa fa-check"></i><b>9.3</b> Phlegmasia</a></li>
<li class="chapter" data-level="9.4" data-path="venous-disease.html"><a href="venous-disease.html#deep-venous-obstruction"><i class="fa fa-check"></i><b>9.4</b> Deep Venous Obstruction</a>
<ul>
<li class="chapter" data-level="9.4.1" data-path="venous-disease.html"><a href="venous-disease.html#etiology-11"><i class="fa fa-check"></i><b>9.4.1</b> Etiology</a></li>
<li class="chapter" data-level="9.4.2" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-19"><i class="fa fa-check"></i><b>9.4.2</b> Evaluation</a></li>
<li class="chapter" data-level="9.4.3" data-path="venous-disease.html"><a href="venous-disease.html#management-31"><i class="fa fa-check"></i><b>9.4.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="9.5" data-path="venous-disease.html"><a href="venous-disease.html#pelvic-congestive-syndrome"><i class="fa fa-check"></i><b>9.5</b> Pelvic Congestive Syndrome</a>
<ul>
<li class="chapter" data-level="9.5.1" data-path="venous-disease.html"><a href="venous-disease.html#presentation-12"><i class="fa fa-check"></i><b>9.5.1</b> Presentation</a></li>
<li class="chapter" data-level="9.5.2" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-and-management"><i class="fa fa-check"></i><b>9.5.2</b> Evaluation and Management</a></li>
</ul></li>
<li class="chapter" data-level="9.6" data-path="venous-disease.html"><a href="venous-disease.html#venous-trauma"><i class="fa fa-check"></i><b>9.6</b> Venous Trauma</a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="vascular-trauma.html"><a href="vascular-trauma.html"><i class="fa fa-check"></i><b>10</b> Vascular Trauma</a>
<ul>
<li class="chapter" data-level="10.1" data-path="vascular-trauma.html"><a href="vascular-trauma.html#peripheral"><i class="fa fa-check"></i><b>10.1</b> Peripheral</a></li>
<li class="chapter" data-level="10.2" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-arterial"><i class="fa fa-check"></i><b>10.2</b> Abdominal Arterial</a></li>
<li class="chapter" data-level="10.3" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-venous"><i class="fa fa-check"></i><b>10.3</b> Abdominal Venous</a></li>
<li class="chapter" data-level="10.4" data-path="vascular-trauma.html"><a href="vascular-trauma.html#cerebrovascular-trauma"><i class="fa fa-check"></i><b>10.4</b> Cerebrovascular Trauma</a></li>
<li class="chapter" data-level="10.5" data-path="vascular-trauma.html"><a href="vascular-trauma.html#endovascular-approaches"><i class="fa fa-check"></i><b>10.5</b> Endovascular Approaches</a></li>
</ul></li>
<li class="chapter" data-level="11" data-path="angioaccess.html"><a href="angioaccess.html"><i class="fa fa-check"></i><b>11</b> Angioaccess</a>
<ul>
<li class="chapter" data-level="11.1" data-path="angioaccess.html"><a href="angioaccess.html#planning-access-creation"><i class="fa fa-check"></i><b>11.1</b> Planning access creation</a></li>
<li class="chapter" data-level="11.2" data-path="angioaccess.html"><a href="angioaccess.html#techniques-for-access-creation"><i class="fa fa-check"></i><b>11.2</b> Techniques for access creation</a></li>
<li class="chapter" data-level="11.3" data-path="angioaccess.html"><a href="angioaccess.html#maintenance-and-complications"><i class="fa fa-check"></i><b>11.3</b> Maintenance and complications</a>
<ul>
<li class="chapter" data-level="11.3.1" data-path="angioaccess.html"><a href="angioaccess.html#failure-to-mature"><i class="fa fa-check"></i><b>11.3.1</b> Failure to mature</a></li>
<li class="chapter" data-level="11.3.2" data-path="angioaccess.html"><a href="angioaccess.html#access-failure"><i class="fa fa-check"></i><b>11.3.2</b> Access Failure</a></li>
<li class="chapter" data-level="11.3.3" data-path="angioaccess.html"><a href="angioaccess.html#sec-steal-syndrome"><i class="fa fa-check"></i><b>11.3.3</b> Steal Syndrome</a></li>
<li class="chapter" data-level="11.3.4" data-path="angioaccess.html"><a href="angioaccess.html#neuropathy-and-neuropraxia"><i class="fa fa-check"></i><b>11.3.4</b> Neuropathy and Neuropraxia</a></li>
<li class="chapter" data-level="11.3.5" data-path="angioaccess.html"><a href="angioaccess.html#perioperative-neuropraxia"><i class="fa fa-check"></i><b>11.3.5</b> Perioperative neuropraxia</a></li>
<li class="chapter" data-level="11.3.6" data-path="angioaccess.html"><a href="angioaccess.html#bleeding-and-aneurysm"><i class="fa fa-check"></i><b>11.3.6</b> Bleeding and Aneurysm</a></li>
</ul></li>
<li class="chapter" data-level="11.4" data-path="angioaccess.html"><a href="angioaccess.html#dialysis-catheters"><i class="fa fa-check"></i><b>11.4</b> Dialysis Catheters</a></li>
<li class="chapter" data-level="11.5" data-path="angioaccess.html"><a href="angioaccess.html#peritoneal-dialysis"><i class="fa fa-check"></i><b>11.5</b> Peritoneal Dialysis</a></li>
</ul></li>
<li class="chapter" data-level="12" data-path="vascular-lab.html"><a href="vascular-lab.html"><i class="fa fa-check"></i><b>12</b> Vascular Lab</a>
<ul>
<li class="chapter" data-level="12.1" data-path="vascular-lab.html"><a href="vascular-lab.html#overview"><i class="fa fa-check"></i><b>12.1</b> <strong>Overview</strong></a>
<ul>
<li class="chapter" data-level="12.1.1" data-path="vascular-lab.html"><a href="vascular-lab.html#waveforms"><i class="fa fa-check"></i><b>12.1.1</b> Waveforms</a></li>
</ul></li>
<li class="chapter" data-level="12.2" data-path="vascular-lab.html"><a href="vascular-lab.html#extracranial"><i class="fa fa-check"></i><b>12.2</b> Extracranial</a></li>
<li class="chapter" data-level="12.3" data-path="vascular-lab.html"><a href="vascular-lab.html#intracranial"><i class="fa fa-check"></i><b>12.3</b> Intracranial</a></li>
<li class="chapter" data-level="12.4" data-path="vascular-lab.html"><a href="vascular-lab.html#upper-extremity"><i class="fa fa-check"></i><b>12.4</b> Upper Extremity</a>
<ul>
<li class="chapter" data-level="12.4.1" data-path="vascular-lab.html"><a href="vascular-lab.html#hemodialysis-access"><i class="fa fa-check"></i><b>12.4.1</b> Hemodialysis Access</a></li>
</ul></li>
<li class="chapter" data-level="12.5" data-path="vascular-lab.html"><a href="vascular-lab.html#lower-extremity"><i class="fa fa-check"></i><b>12.5</b> Lower Extremity</a>
<ul>
<li class="chapter" data-level="12.5.1" data-path="vascular-lab.html"><a href="vascular-lab.html#pathologies"><i class="fa fa-check"></i><b>12.5.1</b> Pathologies</a></li>
</ul></li>
<li class="chapter" data-level="12.6" data-path="vascular-lab.html"><a href="vascular-lab.html#abdominal"><i class="fa fa-check"></i><b>12.6</b> Abdominal</a>
<ul>
<li class="chapter" data-level="12.6.1" data-path="vascular-lab.html"><a href="vascular-lab.html#aorta"><i class="fa fa-check"></i><b>12.6.1</b> Aorta</a></li>
<li class="chapter" data-level="12.6.2" data-path="vascular-lab.html"><a href="vascular-lab.html#mesenteric-vasculature"><i class="fa fa-check"></i><b>12.6.2</b> Mesenteric Vasculature</a></li>
<li class="chapter" data-level="12.6.3" data-path="vascular-lab.html"><a href="vascular-lab.html#portal-vein"><i class="fa fa-check"></i><b>12.6.3</b> Portal Vein</a></li>
<li class="chapter" data-level="12.6.4" data-path="vascular-lab.html"><a href="vascular-lab.html#renal-arteries"><i class="fa fa-check"></i><b>12.6.4</b> Renal arteries</a></li>
</ul></li>
<li class="chapter" data-level="12.7" data-path="vascular-lab.html"><a href="vascular-lab.html#venous"><i class="fa fa-check"></i><b>12.7</b> Venous</a></li>
<li class="chapter" data-level="12.8" data-path="vascular-lab.html"><a href="vascular-lab.html#artifacts"><i class="fa fa-check"></i><b>12.8</b> Artifacts</a></li>
<li class="chapter" data-level="12.9" data-path="vascular-lab.html"><a href="vascular-lab.html#accreditation-and-credentialling"><i class="fa fa-check"></i><b>12.9</b> Accreditation and Credentialling</a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="endovascular-2.html"><a href="endovascular-2.html"><i class="fa fa-check"></i><b>13</b> Endovascular</a>
<ul>
<li class="chapter" data-level="13.1" data-path="endovascular-2.html"><a href="endovascular-2.html#vascular-access"><i class="fa fa-check"></i><b>13.1</b> Vascular Access</a></li>
<li class="chapter" data-level="13.2" data-path="endovascular-2.html"><a href="endovascular-2.html#access-comp"><i class="fa fa-check"></i><b>13.2</b> Complications</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Vascular Surgery Exam Prep</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="cerebrovascular" class="section level1 hasAnchor" number="2">
<h1><span class="header-section-number">2</span> Cerebrovascular<a href="cerebrovascular.html#cerebrovascular" class="anchor-section" aria-label="Anchor link to header"></a></h1>
<p><strong>UNDER CONSTRUCTION - This Chapter is Currently in DRAFT mode</strong></p>
<p><strong>07 Jan 2019:</strong> <em>Adam Johnson, MD, MPH; Nicole Rich, MD, MPH; Kevin
Kniery, MD, MPH</em></p>
<audio controls> <source src='https://traffic.libsyn.com/audiblebleeding/E7_-_Carotid_VSITE.mp3' type='audio/mpeg'> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
<div id="available-guidelines" class="section level2 hasAnchor" number="2.1">
<h2><span class="header-section-number">2.1</span> Available Guidelines<a href="cerebrovascular.html#available-guidelines" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><a href="https://www.jvascsurg.org/article/S0741-5214(21)00893-4/fulltext">Society for Vascular Surgery clinical practice guidelines for
management of extracranial cerebrovascular
disease</a><span class="citation"><sup>[<a href="#ref-aburahmaSocietyVascularSurgery2022" role="doc-biblioref">1</a>]</sup></span></p>
</div>
<div id="presentation-and-diagnosis" class="section level2 hasAnchor" number="2.2">
<h2><span class="header-section-number">2.2</span> Presentation and Diagnosis<a href="cerebrovascular.html#presentation-and-diagnosis" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<ol style="list-style-type: decimal">
<li><p><strong>What is the definition of crescendo TIAs?</strong></p>
<p>The presenting symptoms of extracranial carotid disease is of the
utmost importance to understand. Focal neurologic symptoms that
occur suddenly and then resolve within 24 hours are called a
transient ischemic attach (TIA). If the deficit persists beyond 24
hours, then it is considered a stroke. Strokes are then graded
according to the National Institute of Health Stroke Scale
(NIHSS).<span class="citation"><sup>[<a href="#ref-fischer2010" role="doc-biblioref">2</a>]</sup></span></p>
<p>A particularly confusing distinction is between a crescendo TIA and
a stroke in evolution. A crescendo frequent repetitive neurological
attacks without complete resolution of the deficit between the
episodes, usually over a 24 hour period. The result of which is the
same neurological deficit. If the patient exhibits progressive
deterioration in neurological function between TIA episodes this is
classified as a stroke in evolution not a crescendo TIA.<span class="citation"><sup>[<a href="#ref-ricotta" role="doc-biblioref">3</a>]</sup></span>
These are both particularly concerning findings and may be an
indication for an emergent intervention.</p></li>
<li><p><strong>Who needs to be screened for carotid disease?</strong></p>
<p>Not everyone should be screened for carotid disease, however, as
only 15% of patients who have a stroke experience a warning TIA
prior to their event, there is merit in screening high risk
patients.<span class="citation"><sup>[<a href="#ref-rockman2019" role="doc-biblioref">4</a>]</sup></span> The purpose of carotid bifurcation imaging
is to detect “stroke-prone” carotid bifurcation plaque and identify
a high-risk patient likely to benefit from therapy designed to
reduce stroke risk.</p>
<p>Traditionally, the clinical sign associated with asymptomatic
carotid stenosis is the presence of a neck bruit on auscultation.
Focal ipsilateral carotid bruits in symptomatic patients has a
sensitivity of 63% and a specificity of 61% for high-grade carotid
stenosis (range, 70%-99%). As these figures suggest the absence of
carotid bruit does not absolutely exclude the presence of a
significant carotid bifurcation lesion, therefore additional
criteria are used to determine which patients would benefit from
screening:</p>
<ul>
<li><p>Evidence of clinically significant peripheral vascular disease
regardless of age</p></li>
<li><p>Patients aged &gt;65 years with a history of one or more of the
following atherosclerotic risk factors:</p>
<ul>
<li><p>CAD</p></li>
<li><p>Smoking</p></li>
<li><p>Hypercholesterolemia</p></li>
</ul></li>
</ul>
<p>In general, the more risk factors present, the higher the yield of
screening for the patient. Presence of a carotid bruit, AAA or
family history of disease alone is not sufficient to warrant
imaging.<span class="citation"><sup>[<a href="#ref-aburahma2022" role="doc-biblioref">5</a>]</sup></span></p></li>
<li><p><strong>Ultrasound Imaging</strong></p>
<ul>
<li><p>US is considered the best, least invasive, and cost effective
method for detecting carotid stenosis on
screening.<span class="citation"><sup>[<a href="#ref-shaalan2008" role="doc-biblioref">6</a>]</sup></span> For more see <a href="vascular-lab.html#extracranial">12.2</a>.</p></li>
<li><p>50-69% stenosis of ICA - US has a low sensitivity for 50-69%
stenosis. A negative ultrasound in symptomatic patients
necessitates additional imaging. Typically on scanning if 50-69%
ICA stenosis is present:</p>
<ul>
<li>PSV 125-229 cm/sec</li>
<li>EDV 40-100</li>
<li>Internal/Common Carotid PSV Ratio 2-4</li>
</ul></li>
<li><p>70-99% stenosis of ICA- Typically on scanning:</p>
<ul>
<li><p>PSV &gt;/= 230 cm/sec</p></li>
<li><p>EDV &gt;100 (EDV &gt; 140 cm/sec most sensitive for stenosis
&gt;80%)</p></li>
<li><p>Internal/Common Carotid PSV Ratio &gt; 4</p></li>
</ul></li>
<li><p>Velocity-based estimation of carotid artery stenosis may need to
be adjusted in certain circumstances:</p>
<ul>
<li><p>Higher velocities in women than in men.</p></li>
<li><p>Higher velocities in the presence of contralateral carotid
artery occlusion.</p></li>
</ul></li>
<li><p>High carotid bifurcation, severe arterial tortuosity, extensive
vascular calcification, and obesity may also reduce the accuracy
of US imaging.</p></li>
</ul></li>
<li><p><strong>Other Imaging Modalities</strong></p>
<ul>
<li><p>CTA</p>
<ul>
<li><p>Pro - fast, sub-millimeter spatial resolution, visualize
surrounding structures.</p></li>
<li><p>Con - cost, contrast exposure.</p></li>
</ul></li>
<li><p>MRA</p>
<ul>
<li><p>Pro - no contrast administered; can analyze plaque
morphology.</p></li>
<li><p>Con - Does not visualize calcium in plaque; overestimates
the degree of stenosis (False positive for 50-69% to be read
as &gt;70%).</p></li>
</ul></li>
<li><p>Catheter-based digital subtraction imaging (DSA)</p>
<ul>
<li><p>Still considered by many the gold-standard imaging modality.</p></li>
<li><p>Reserved for individuals with conflicting less-invasive
imaging or those considered for CAS.</p></li>
<li><p>Con - cost, contrast, and risk of stroke.</p></li>
</ul></li>
</ul></li>
</ol>
</div>
<div id="management" class="section level2 hasAnchor" number="2.3">
<h2><span class="header-section-number">2.3</span> Management<a href="cerebrovascular.html#management" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<div id="medical-management---asymptomatic-patients" class="section level3 hasAnchor" number="2.3.1">
<h3><span class="header-section-number">2.3.1</span> Medical Management - Asymptomatic Patients<a href="cerebrovascular.html#medical-management---asymptomatic-patients" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>First line management for asymptomatic patients with carotid stenosis is
medical optimization of risk factors. The benefit of prophylactic
intervention (CEA/CAS) of even high grade stenosis is estimated at a
1-2% stroke reduction risk per year.<span class="citation"><sup>[<a href="#ref-naylorWhyManagementAsymptomatic2015" role="doc-biblioref">7</a>]</sup></span> In addition, keep in mind that
intervention (CEA/CAS) has only demonstrated a benefit in asymptomatic
patient with life expectancy greater than 3 years.<span class="citation"><sup>[<a href="#ref-bulbuliaAsymptomaticCarotidSurgery2017" role="doc-biblioref">8</a>–<a href="#ref-rosenfieldRandomizedTrialStent2016" role="doc-biblioref">10</a>]</sup></span></p>
<p><strong>Hypertension</strong></p>
<ul>
<li><p>Blood pressure reduction, with a target of &lt;140/90 mmHg through
lifestyle interventions and anti-hypertensive treatment is
recommended in individuals who have hypertension with asymptomatic
carotid atherosclerosis or those with TIA or stroke after the
hyper-acute period.</p></li>
<li><p>Each 10-mm Hg reduction in blood pressure among hypertensive
patients decreases the risk of stroke by 33% in patients aged
60-79.<span class="citation"><sup>[<a href="#ref-aiyagari2009" role="doc-biblioref">11</a>]</sup></span></p></li>
</ul>
<p><strong>Diabetes</strong></p>
<ul>
<li>In diabetic patients glycaemic control to nearly normoglycemic
levels (target hemoglobin A1C &lt;7%) is recommended to reduce
microvascular complications and, with a smaller evidence base,
macrovascular complications other than stroke.<span class="citation"><sup>[<a href="#ref-ricotta" role="doc-biblioref">3</a>]</sup></span></li>
</ul>
<p><strong>Hypercholesterolaemia</strong></p>
<ul>
<li><p>Statin agents are recommended targeting LDL of 100 mg/dL, for those
with coronary heart disease or symptomatic atherosclerotic disease,
and LDL of 70 mg/dL for very high-risk persons with multiple risk
factors.</p></li>
<li><p>High dose statin therapy in patients with TIA/stroke reduce future
rates of stroke or cardiovascular events but not overall mortality
at 5 years.<span class="citation"><sup>[<a href="#ref-karamHighDoseAtorvastatinStroke2008" role="doc-biblioref">12</a>]</sup></span></p></li>
</ul>
<p><strong>Smoking Cessation</strong> - Encouraging smoking cessation is paramount for
these patients. Smoking and carotid disease have been found to have a
dose dependent relationship based on pack-years. Risk of stroke has been
shown to reduce to baseline within 2-4 years of smoking
cessation.<span class="citation"><sup>[<a href="#ref-hicks2015" role="doc-biblioref">13</a>–<a href="#ref-wilson1997" role="doc-biblioref">16</a>]</sup></span></p>
<p><strong>Antiplatelet therapy</strong> - Single agent antiplatelet therapy, most often
aspirin, is often all that is needed, but this should be weighted with
other cardiovascular risk factors. A number of trials have showed
limited benefit of adding an additional antiplatelet or routinely
testing for clopidogrel resistance.<span class="citation"><sup>[<a href="#ref-ricotta" role="doc-biblioref">3</a>]</sup></span></p>
</div>
<div id="medical-management---symptomatic-patients" class="section level3 hasAnchor" number="2.3.2">
<h3><span class="header-section-number">2.3.2</span> Medical Management - Symptomatic Patients<a href="cerebrovascular.html#medical-management---symptomatic-patients" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Patients who present with a TIA should be placed on dual antiplatelet
therapy, often aspirin and clopidogrel, which are continued through the
workup and treatment of carotid disease. Patients often also have their
blood pressure medications reduced to allow permissive hypertension and
maximize perfusion to at risk cerebral tissue.</p>
<p>While we are not often directly involved in the management of acute
stroke, vascular surgeons should be aware of best practices in this
area. Management of acute stroke currently follow these
timelines<span class="citation"><sup>[<a href="#ref-powers2018GuidelinesEarly2018" role="doc-biblioref">17</a>]</sup></span></p>
<ul>
<li><p>&lt; 4.5 hours from onset of symptoms - medical thrombolysis with tPA
unless contraindicated.</p>
<ul>
<li>Patient age &gt;80 and diabetes are contraindications to tPA
administration after 3hrs.</li>
<li>Other contraindications include - hypertension, intracranial
hemorrhage, recent stroke or cranial trauma, spine/brain surgery
within 3 months, GI bleed within 21 days.</li>
</ul></li>
<li><p>&lt;6 hours from onset of symptoms - catheter directed therapy</p></li>
<li><p>After 6 hours, there is limited benefit to thrombolytic therapy.</p></li>
</ul>
</div>
<div id="surgery---carotid-endarterectomy" class="section level3 hasAnchor" number="2.3.3">
<h3><span class="header-section-number">2.3.3</span> Surgery - Carotid Endarterectomy<a href="cerebrovascular.html#surgery---carotid-endarterectomy" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>Indications for Surgical Intervention</strong></p>
<ul>
<li><p>Recommendations on when to operate after a TIA/stroke.</p>
<ul>
<li><p>Acute stroke with a fixed neurologic deficit of &gt;6h duration -
When the patient is medically stable, intervention in 14 days or
less after stroke is preferable.<span class="citation"><sup>[<a href="#ref-rothwellEndarterectomySymptomaticCarotid2004" role="doc-biblioref">18</a>,<a href="#ref-meershoekTimingCarotidIntervention2018" role="doc-biblioref">19</a>]</sup></span></p></li>
<li><p>Consider urgent intervention in a medically stable patient with
mild-moderate neurologic deficit, if there is a significant area
of ischemic penumbra at risk for progression on imaging that is
contributing to the patient’s presentation.</p></li>
<li><p>Stroke in evolution (fluctuating / evolving neurological
deficit) or crescendo TIA (repetitive transient ischemia with
improvement between events) - If the patient’s neurological
status is not stabilized by medical intervention then an urgent
CEA should be considered.</p></li>
<li><p>In this clinical context CEA is preferred to CAS based on an
increased embolic potential of carotid lesions.<span class="citation"><sup>[<a href="#ref-rantnerEarlyEndarterectomyCarries2017" role="doc-biblioref">20</a>]</sup></span></p></li>
</ul></li>
<li><p>What is the only emergent indication for CEA?</p>
<ul>
<li>Crescendo TIAs or a stroke in evolution with a surgically
correctable lesion identified on imaging.</li>
</ul></li>
</ul>
<p><strong>CEA Intraoperative Techniques</strong></p>
<ul>
<li><p>General concepts</p>
<ul>
<li>Patch angioplasty or eversion endarterectomy are recommended
over primary arterial closure due to decreased ipsilateral
stroke, perioperative carotid occlusion, return to the operating
room, restenosis and 1-year stroke rates.<span class="citation"><sup>[<a href="#ref-goodney2010" role="doc-biblioref">21</a>,<a href="#ref-rerkasem2009" role="doc-biblioref">22</a>]</sup></span> Patch repair is considered the standard of care
surgical management for most extracranial carotid
lesions.<span class="citation"><sup>[<a href="#ref-arnold2019" role="doc-biblioref">23</a>]</sup></span></li>
</ul></li>
<li><p>Neuromonitoring/Shunting options during a carotid
endarterectomy<span class="citation"><sup>[<a href="#ref-chongruksut2014" role="doc-biblioref">24</a>,<a href="#ref-wiske2018" role="doc-biblioref">25</a>]</sup></span></p>
<ul>
<li><p>Local/regional anesthesia with direct neurological monitoring -
the benefit being that the patient is awake and moving to
command throughout the case. Indications for shunting include
lateralizing deficits, seizure, lack of consciousness and severe
anxiety. Improved neuromonitoring, however, has not been shown
to reduce myocardial infarction rate with CEA.</p></li>
<li><p>Stump pressure- Clamp the inflow and place a butterfly attached
to a-line tubing into the internal carotid artery. If the stump
pressure is &gt; 50 mmHg the surgeon can chose to proceed without
shunt placement, if &lt; 50mmHg then a shunt should be placed
prior to proceeding.</p></li>
<li><p>EEG Neuromonitoring - EEG tech places neuromonitoring, monitored
by the technician and neurologist remotely intraoperatively.
Generally the surgeon should clamp the ICA for 3 minutes before
proceeding, if the patient develops neurological deficit/EEG
abnormalities with slowing and decreased alpha and beta waves,
then unclamp, await normalization of EEG, then proceed.</p></li>
<li><p>Cerebral Oximetry - 15% decrease in either hemisphere should be
shunted.</p></li>
<li><p>Transcranial Doppler (TCD) - severe slowing in the middle
cerebral artery. An RCT demonstrated that TCD and cerebral
oximetry changes most accurately predicted cerebral ischemia.
Detection of a greater than 50% drop in middle cerebral artery
velocity using transcranial Doppler is 100% sensitive for
detecting cerebral ischemia.<span class="citation"><sup>[<a href="#ref-moritz2007" role="doc-biblioref">26</a>]</sup></span> For more see
<a href="vascular-lab.html#intracranial">12.3</a>.</p></li>
<li><p>Non-selective shunting - the surgeon uses a shunt for all CEAs
as standard practice, this is often done for all CEAs performed
under general anesthesia</p></li>
</ul></li>
<li><p>Techniques to reach high internal carotid lesions?<span class="citation"><sup>[<a href="#ref-beretta2006" role="doc-biblioref">27</a>]</sup></span></p>
<ul>
<li><p>A good knowledge of the available imaging while preparing for
the procedure is essential when considering the level of the
carotid bifurcation.</p></li>
<li><p>Nasotracheal intubation will allow for jaw closure and neck
extension to facilitate exposure of higher lesions.</p></li>
<li><p>Division of the posterior belly of the digastric muscle,
stylopharyngeal muscle, styloglossus muscle, stylomandibular
ligament or the styloid process. Care should be taken to
identify and preserve the glossopharyngeal nerve.</p></li>
<li><p>Division of the occipital artery.</p></li>
<li><p>Dissection along the posterior parotid gland.</p></li>
<li><p>ENT surgeon assisted mandible subluxation with assistance if
previous techniques fail.</p></li>
</ul></li>
<li><p>What is the best technique for a patient with an anatomically kinked
internal carotid artery?</p>
<ul>
<li><p>Eversion carotid endarterectomy (only indication for selection
for this technique over patch endarterectomy), transection
allows for reduction of redundancy at re-anastamosis.</p></li>
<li><p>Otherwise, no advantage has been shown between eversion or
patch, both can be shunted.</p></li>
</ul></li>
<li><p>Nerve Injuries – where you would encounter these and, if injured,
what deficit would be seen?</p>
<ul>
<li><p>Hypoglossal: Most commonly injured. Usually passes above the
bifurcation of the carotid artery. If injured the tongue will
deviate toward the side of injury on protrusion.</p></li>
<li><p>Glossopharyngeal: Commonly injured during high dissections.
Found under the posterior digastric muscle. Injury can be
devastating for patients resulting in difficulty swallowing and
high aspiration risk.</p></li>
<li><p>Vagus: Usually found adjacent and lateral to the common carotid.
Injury can occur with carotid clamping. Patients develop
hoarseness due to innervation of the laryngeal muscles from the
recurrent laryngeal nerve which is a branch of the vagus.</p></li>
<li><p>Marginal Mandibular: Branch of the facial nerve. Runs inferiorly
to the angle of the mandible. Commonly a retraction injury
during high dissections leading to the corner of the ipsilateral
lip drooping, can be confused with a significant neurological
deficit following the case.</p></li>
</ul></li>
<li><p>Completion duplex for CEA</p>
<ul>
<li><p>Can identify technical issues with carotid endarterectomy such
as clamp site injury, thrombosis, intimal flap or dissection, or
missed disease.<span class="citation"><sup>[<a href="#ref-lipski1996" role="doc-biblioref">28</a>]</sup></span></p>
<ul>
<li>Acute thrombus may be hypoechoic and difficult to see on
B-mode, color flow necessary to determine luminal narrowing
or occlusion. For more see <a href="vascular-lab.html#extracranial">12.2</a>.</li>
</ul></li>
<li><p>Revision required if residual plaque identified with severe
velocity elevation.<span class="citation"><sup>[<a href="#ref-weinstein2015" role="doc-biblioref">29</a>]</sup></span></p>
<ul>
<li>Elevated velocities can be seen for many reasons that do not
require revision, including incorrect technique (compression
with probe), tortuosity, size discrepancy, ICA
spasm.<span class="citation"><sup>[<a href="#ref-weinstein2015" role="doc-biblioref">29</a>,<a href="#ref-ricco2013" role="doc-biblioref">30</a>]</sup></span></li>
</ul></li>
<li><p>One study demonstrated that 2.3% of carotids required revision
for concerning findings on completion duplex
ultrasound.<span class="citation"><sup>[<a href="#ref-ascher2004" role="doc-biblioref">31</a>]</sup></span></p></li>
</ul></li>
</ul>
<p><strong>Postoperative Complications</strong></p>
<ul>
<li><p>What to do if the patient develops neuro deficits following carotid
endarterectomy: Two main concerns- an intimal flap causing
thrombosis or an embolic event resulting in a stroke. Perform a
thorough neurological exam to confirm in operated carotid territory.</p>
<ul>
<li><p>If in OR – perform duplex, very low threshold to re-explore and
confirm patency of ICA with duplex or doppler. If ICA open and
concerned for distal embolization, then perform a cerebral
angiogram and proceed with thrombolysis or
thrombectomy.<span class="citation"><sup>[<a href="#ref-fletcher2016" role="doc-biblioref">32</a>]</sup></span></p></li>
<li><p>If in Recovery or on the floor – many would consider CTA first
line vs duplex to look for thrombosis.</p></li>
</ul></li>
<li><p>Risk factors and how to manage hyperperfusion syndrome?</p>
<ul>
<li><p>Defined as an ipsilateral headache, hypertension, neurological
deficits likely in distribution of the carotid which can
progress to seizures and intracranial hemorrhage (75-100%
mortality). Can present 2-3 days post surgery.<span class="citation"><sup>[<a href="#ref-kaku2004" role="doc-biblioref">33</a>]</sup></span></p></li>
<li><p>Patients with uncontrolled hypertension are at risk for
hyperperfusion syndrome, clinical practice guidelines from SVS
recommend strict BP control following CEA, with target pressure
being less than 140/80mmHg or 20mmHg from preoperative
baseline.<span class="citation"><sup>[<a href="#ref-abou-chebl2004" role="doc-biblioref">34</a>]</sup></span></p></li>
</ul></li>
<li><p>High risk groups</p>
<ul>
<li>ESRD patients have higher rates of perioperative stroke, but
also have higher rates of stroke if not revascularized.<span class="citation"><sup>[<a href="#ref-klarinPerioperativeLongtermImpact2016" role="doc-biblioref">35</a>]</sup></span></li>
</ul></li>
</ul>
<p><strong>Long term complications and follow up</strong></p>
<ul>
<li><p>Recommend f/u US duplex of bilateral carotids at &lt;/=30 days. &gt;/=
50% stenosis further imaging is indicated.</p></li>
<li><p>Ipsilateral stenosis</p>
<ul>
<li><p>0-3mo likely due to inadequate endarterectomy or clamp
injury.<span class="citation"><sup>[<a href="#ref-kang2014" role="doc-biblioref">36</a>]</sup></span></p></li>
<li><p>1-3y likely neointimal hyperplasia, smooth and regular. If &lt;80%
stenosis and asymptomatic, then duplex surveillance and
antiplatelet. If progresses, then often endo treatment
first.<span class="citation"><sup>[<a href="#ref-garzon-muvdi2016" role="doc-biblioref">37</a>]</sup></span></p></li>
</ul></li>
<li><p>Contralateral stenosis:</p>
<ul>
<li><p>The risk of progression for moderate stenosis at the initial
surveillance to severe stenosis in the contralateral artery can
be as high as 5 times.</p></li>
<li><p>Requires post-operative surveillance.</p></li>
</ul></li>
<li><p>Carotid artery patch infections</p>
<ul>
<li><p>Rare complication (&lt;1%) presenting as phlegmon, pseudoaneurysm,
sinus tract or carotid cutaneous fistula.<span class="citation"><sup>[<a href="#ref-stone2011" role="doc-biblioref">38</a>]</sup></span></p></li>
<li><p>Treatment is excision and replacement with autologous
tissue.<span class="citation"><sup>[<a href="#ref-fatima2019" role="doc-biblioref">39</a>]</sup></span></p></li>
</ul></li>
</ul>
</div>
<div id="endovascular---carotid-artery-stenting" class="section level3 hasAnchor" number="2.3.4">
<h3><span class="header-section-number">2.3.4</span> Endovascular - Carotid Artery Stenting<a href="cerebrovascular.html#endovascular---carotid-artery-stenting" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ul>
<li><p>In patients aged &gt;70 the risk of intra- or post procedure stroke
was the highest, if undergoing CAS, presumably due to calcified
disease in the arch.</p>
<ul>
<li><p>Lesion-specific characteristics are thought to increase the risk
of cerebral vascular events after CAS and include a “soft”
lipid-rich plaque identified on noninvasive imaging, extensive
(15 mm or more) disease, a pre-occlusive lesion, and
circumferential heavy calcification.</p></li>
<li><p>This risk can be reduced, but not eliminated, by using
flow-reversal embolic protection rather than distal filter
protection.</p></li>
</ul></li>
<li><p>Limited data is available on CAS in asymptomatic patients -
currently is not supported by guidelines or considered reimbursable.</p></li>
<li><p>Consider CAS in symptomatic patients with &gt;50% stenosis who are
poor candidates for CEA due to severe uncorrectable medical
comorbidities and/or anatomic considerations:</p>
<ul>
<li><p>Ipsilateral neck dissection or XRT - equivalent periprocedural
stroke rate to CEA, but increased later stroke rate. CEA higher
rates of cranial nerve damage (9%).<span class="citation"><sup>[<a href="#ref-giannopoulosRevascularizationRadiationinducedCarotid2018" role="doc-biblioref">40</a>]</sup></span></p></li>
<li><p>Contralateral vocal cord paralysis.</p></li>
<li><p>Lesions that extend proximally to the clavicle or distal to C2.</p></li>
</ul></li>
<li><p>Transfemoral Approach vs Transcarotid approach</p>
<ul>
<li>ROADSTER Trial - single arm study with flow reversal for
cerebral protection. Suggested lower rates of post-op stroke in
patients undergoing TCAR.</li>
<li>TCAR contraindications include previous CCA intervention, CCA
disease at entry site, &lt;5cm CCA (clavicle to bifurcation) for
sheath, CCA &lt; 6mm, contralateral recurrent laryngeal or vagus
nerve injury.<span class="citation"><sup>[<a href="#ref-kwolek2015" role="doc-biblioref">41</a>]</sup></span></li>
<li>Patient needs to be preloaded with dual antiplatelet medications
for at least 5-7d, should delay procedure if has not been
appropriately loaded with antiplatelets.<span class="citation"><sup>[<a href="#ref-kwolek2015" role="doc-biblioref">41</a>–<a href="#ref-valls2017" role="doc-biblioref">43</a>]</sup></span></li>
<li>Studies with TCD have shown that there may be reduced
embolization rates with TCAR over transfemoral
stenting.<span class="citation"><sup>[<a href="#ref-plessers2016" role="doc-biblioref">44</a>]</sup></span></li>
</ul></li>
<li><p>Complications</p>
<ul>
<li>Post stenting ICA thrombosis should first be treated with
abciximab and catheter directed thrombolysis, followed by
endo-salvage with suction thrombectomy, repeat angioplasty or
stenting. May require eventual conversion to CEA.<span class="citation"><sup>[<a href="#ref-coelho2019" role="doc-biblioref">45</a>,<a href="#ref-naylor2018" role="doc-biblioref">46</a>]</sup></span></li>
</ul></li>
<li><p>Post-CAS follow up - Dual-platelet therapy should be continued for 1
month after the procedure, and aspirin should be continued
indefinitely.</p>
<ul>
<li>In stent restenosis (&gt;50%) - 4-times higher rate of stroke than
no recurrence of disease, but more benign than de novo
disease.<span class="citation"><sup>[<a href="#ref-clavel2019" role="doc-biblioref">47</a>]</sup></span> Stenosis should be confirmed with CTA. No
clear difference between treatments in literature - PBA,
Cutting, DBA, stenting, open conversion.<span class="citation"><sup>[<a href="#ref-arhuidese2017" role="doc-biblioref">48</a>]</sup></span> Repeat
angioplasty or stent have low incidence of periprocedural stroke
but failed to improve long term stroke/death/MI or patency
rates.<span class="citation"><sup>[<a href="#ref-chungPercutaneousInterventionCarotid2016a" role="doc-biblioref">49</a>]</sup></span></li>
</ul></li>
</ul>
</div>
<div id="summary-of-prospective-trials" class="section level3 hasAnchor" number="2.3.5">
<h3><span class="header-section-number">2.3.5</span> Summary of Prospective Trials<a href="cerebrovascular.html#summary-of-prospective-trials" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ol style="list-style-type: decimal">
<li><p>Asymptomatic Carotid Atherosclerosis Study (ACAS)</p>
<ul>
<li><p>Compared medical management with CEA in asymptomatic patients
with &gt; 60% stenosis.</p></li>
<li><p>5-year stroke and death rate was 5.1% vs 11%.</p></li>
<li><p>In women, the benefit of CEA was not as certain as 5y stroke and
death rates were 7.3% vs. 8.7%.</p></li>
<li><p>This trial was conducted pre-statin and clopidogrel era.</p></li>
</ul></li>
<li><p>North American Symptomatic Carotid Endarterectomy Trial (NASCET)<span class="citation"><sup>[<a href="#ref-northamericansymptomaticcarotidendarterectomytrialcollaboratorsBeneficialEffectCarotid1991" role="doc-biblioref">50</a>]</sup></span></p>
<ul>
<li><p>Compared medical management vs CEA for symptomatic patients with
moderate (50-69%) and severe stenosis (&gt;70%)</p></li>
<li><p>Only moderate impact for patients with moderate stenosis
(50-69%)</p></li>
<li><p>Symptomatic patients with &gt;70 % stenosis benefited from CEA, at
18 months 7% major stroke in surgical arm, and a 24% stroke rate
in medical arm. 29% reduction in 5-year risk of stroke or death.</p>
<ul>
<li>Patients with severe &gt;70% stenosis had such a dramatic
effect the trial was stopped early for this subset and all
referred for endarterectomy.</li>
</ul></li>
<li><p>No benefit is shown in symptomatic patients with &lt; 50% stenosis</p></li>
<li><p>European studies have shown similar results</p>
<ul>
<li><p>ACST = ACAS</p></li>
<li><p>ECST = NASCET.</p></li>
</ul></li>
<li><p><strong>Take a listen!</strong> <a href="https://www.audiblebleeding.com/2021/09/29/landmark-papers-nascet/">Click hear to listen to Dr. William Jordan
discuss this landmark
paper!</a></p></li>
</ul></li>
<li><p>Carotid Revascularization Endarterectomy versus Stenting Trial
(CREST).<span class="citation"><sup>[<a href="#ref-silver2011" role="doc-biblioref">51</a>]</sup></span></p>
<ul>
<li><p>Compared CEA vs. CAS in both symptomatic and asymptomatic
patients.</p></li>
<li><p>Composite endpoint of 30-day stroke, MI, death equivalent
between CEA and CAS.</p></li>
<li><p>CAS had a significantly higher incidence of stroke and death
than CEA and CEA higher incidence of MI.</p>
<ul>
<li>Follow up at 10 years demonstrated no difference in
composite stroke/MI/death but increased rate of stroke/death
in stented patients likely attributable to increased
periprocedural stroke.<span class="citation"><sup>[<a href="#ref-brottLongTermResultsStenting2016b" role="doc-biblioref">52</a>]</sup></span></li>
<li>CAS patients with stroke had a higher impact on QOL than CEA
patients with MI.<span class="citation"><sup>[<a href="#ref-brott2010" role="doc-biblioref">42</a>,<a href="#ref-redfern2011" role="doc-biblioref">53</a>,<a href="#ref-mantese2010" role="doc-biblioref">54</a>]</sup></span></li>
</ul></li>
<li><p>Subanalyses identified that older patients (&gt;70y) had better
outcomes after CEA than CAS, the QOL impact of stroke was more
significant than that of MI, and anatomic characteristics of
carotid lesions (longer, sequential, remote) were predictive of
increased stroke and death after CAS.</p></li>
<li><p>Unfortunately, this study provides a benchmark to strive for,
but no other large trials have achieved these results.</p></li>
</ul></li>
<li><p>ROADSTER<span class="citation"><sup>[<a href="#ref-kwolek2015" role="doc-biblioref">41</a>]</sup></span></p>
<ul>
<li><p>Single arm feasibility trial of transcarotid carotid stenting.</p></li>
<li><p>The results of the ROADSTER trial demonstrate that the use of
the ENROUTE Transcarotid NPS is safe and effective at preventing
stroke during CAS. The overall stroke rate of 1.4% is the lowest
reported to date for any prospective, multicenter clinical trial
of CAS (i.e. CREST). No direct comparison.</p></li>
</ul></li>
<li><p>Trials to look out for in the next few years:</p>
<ul>
<li><p>CREST-2 - a multicenter, randomized controlled trial underway
evaluating revascularization against modern intensive medical
management.</p></li>
<li><p>ACT-1 and ACST-2- the role of intervention in asymptomatic
patients, designed to compare the early and long-term results of
CEA vs CAS and best medical management.</p></li>
<li><p>ROADSTER-2 - TCAR.</p></li>
</ul></li>
</ol>
</div>
</div>
<div id="uncommon-carotid-disease" class="section level2 hasAnchor" number="2.4">
<h2><span class="header-section-number">2.4</span> Uncommon Carotid Disease<a href="cerebrovascular.html#uncommon-carotid-disease" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<div id="complicated-extracranial-occlusive-disease" class="section level3 hasAnchor" number="2.4.1">
<h3><span class="header-section-number">2.4.1</span> Complicated Extracranial Occlusive Disease<a href="cerebrovascular.html#complicated-extracranial-occlusive-disease" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ul>
<li><p>Occluded Carotid: What is the management of an occluded carotid?</p>
<ul>
<li>Leave it alone.</li>
</ul></li>
<li><p>What if an occluded carotid on imaging is still causing TIAs?</p>
<ul>
<li><p>Ongoing symptoms in the setting of carotid occlusion is known as
carotid artery stump syndrome. Symptoms are likely due to emboli
from friable intima of the internal carotid or from the external
carotid through collaterals. Treatment is external carotid
endarterectomy and ligation of the internal carotid.<span class="citation"><sup>[<a href="#ref-hrbác2012" role="doc-biblioref">55</a>]</sup></span></p></li>
<li><p>The addition of oral anticoagulation is likely to reduce the
rate of recurrent stroke.</p></li>
</ul></li>
<li><p>Simultaneous coronary and carotid disease</p>
<ul>
<li><p>Patients with symptomatic carotid stenosis will benefit from CEA
before or concomitant with CABG. The timing of the intervention
depends on the clinical presentation and institutional
experience (GRADE 1, Level of Evidence B).</p></li>
<li><p>Patients with severe bilateral asymptomatic carotid stenosis,
including stenosis and contralateral occlusion, should be
considered for CEA before or concomitant with CABG (GRADE 2,
Level of Evidence B).</p></li>
<li><p>Patients undergoing simultaneous CEA/CABG demonstrate highest
mortality.<span class="citation"><sup>[<a href="#ref-naylorSystematicReviewOutcomes2003" role="doc-biblioref">56</a>]</sup></span></p></li>
</ul></li>
<li><p>What about tandem lesions in the carotid in a symptomatic patient,
carotid bulb and carotid siphon lesion (high ICA)? How should you
treat this?</p>
<ul>
<li>Treat carotid bulb and extracranial disease first, likely to be
the embolic source.</li>
<li>Treatment of intracranial disease has been shown to increase
rates of stroke and death.<span class="citation"><sup>[<a href="#ref-chimowitz2011" role="doc-biblioref">57</a>]</sup></span>. Extracranial to
intracranial bypass has increased risk of stroke over
BMT.<span class="citation"><sup>[<a href="#ref-ec/icbypassstudygroup1985" role="doc-biblioref">58</a>]</sup></span></li>
</ul></li>
<li><p>What if the patient has severe vertebrobasilar insufficiency and
carotid artery disease?</p>
<ul>
<li>Should undergo carotid revascularization first to improve flow.
Then reassess for vertebrobasilar insufficiency.</li>
<li>Vertebrobasilar insufficiency characterized by dizziness,
ataxia, nausea, vertigo and bilateral weakness.<span class="citation"><sup>[<a href="#ref-limanetoPathophysiologyDiagnosisVertebrobasilar2017" role="doc-biblioref">59</a>,<a href="#ref-nouh2014" role="doc-biblioref">60</a>]</sup></span></li>
</ul></li>
</ul>
</div>
<div id="vertebrobasilar-disease" class="section level3 hasAnchor" number="2.4.2">
<h3><span class="header-section-number">2.4.2</span> Vertebrobasilar Disease<a href="cerebrovascular.html#vertebrobasilar-disease" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ul>
<li><p>How do you treat isolated vertebral disease?</p>
<ul>
<li>Most common etiology is atherosclerosis, but can also be caused
by embolism, dissection or migraines.<span class="citation"><sup>[<a href="#ref-limaneto2017" role="doc-biblioref">61</a>]</sup></span></li>
<li>Symptomatic primary vertebral disease with &gt;60% stenosis should
be treated. Vertebral divided into segments. V1 preforaminal
(lower than C6), V2 foraminal (C6-C2), V3 (C2-dura), V4
(intracranial).<span class="citation"><sup>[<a href="#ref-morasch2019" role="doc-biblioref">62</a>,<a href="#ref-berguer1998" role="doc-biblioref">63</a>]</sup></span></li>
<li>Disease of V1 should be treated with vertebral transposition of
bypass with vein.<span class="citation"><sup>[<a href="#ref-rangel-castilla2015" role="doc-biblioref">64</a>]</sup></span>
<ul>
<li>Most common complication is Horner’s Syndrome due to
disruption of the sympathetic chain (20%), next is TIA
(1-3%).<span class="citation"><sup>[<a href="#ref-coleman2013" role="doc-biblioref">65</a>,<a href="#ref-ramirez2012" role="doc-biblioref">66</a>]</sup></span></li>
</ul></li>
<li>Disease of V2 is most difficult to access and should be treated
with bypass from ICA to V3.<span class="citation"><sup>[<a href="#ref-berguer1985" role="doc-biblioref">67</a>]</sup></span></li>
<li>RCT of BMT vs endo treatment did not show superiority of endo
treatment, recurrent symptoms most common, periprocedural stroke
was rare.<span class="citation"><sup>[<a href="#ref-antoniou2012" role="doc-biblioref">68</a>,<a href="#ref-coward2007" role="doc-biblioref">69</a>]</sup></span></li>
</ul></li>
</ul>
</div>
<div id="carotid-artery-dissection" class="section level3 hasAnchor" number="2.4.3">
<h3><span class="header-section-number">2.4.3</span> Carotid artery dissection<a href="cerebrovascular.html#carotid-artery-dissection" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ul>
<li>Patients with carotid dissection should be initially treated with
antithrombotic therapy (antiplatelet agents or anticoagulation)
(GRADE 1, Level of Evidence C).</li>
<li>Indications for endovascular treatment of carotid artery dissection<span class="citation"><sup>[<a href="#ref-cohenSinglecenterExperienceEndovascular2012" role="doc-biblioref">70</a>–<a href="#ref-phamEndovascularStentingExtracranial2011" role="doc-biblioref">72</a>]</sup></span>
<ul>
<li><p>Ongoing symptoms on best medical therapy</p></li>
<li><p>Contraindication to antithrombotics</p></li>
<li><p>Pseudoaneurysm</p></li>
</ul></li>
</ul>
</div>
<div id="internal-carotid-artery-aneurysms" class="section level3 hasAnchor" number="2.4.4">
<h3><span class="header-section-number">2.4.4</span> Internal Carotid Artery Aneurysms<a href="cerebrovascular.html#internal-carotid-artery-aneurysms" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ul>
<li><p>Defined as dilation of the bulb 200% of the internal carotid artery
or 150% of the common carotid artery. Like popliteal aneurysms the
major risk is thromboembolization.<span class="citation"><sup>[<a href="#ref-bush2019" role="doc-biblioref">73</a>–<a href="#ref-pourier2018" role="doc-biblioref">75</a>]</sup></span></p></li>
<li><p>Treatment is resection with primary repair or interposition.
Distorted anatomy increased the risk for cranial nerve injury
(12%).<span class="citation"><sup>[<a href="#ref-welleweerd2015" role="doc-biblioref">76</a>]</sup></span></p></li>
<li><p>Redundant ICA - should be repaired if patient symptomatic due to
kinking. Treated with resection and primary repair with shortening
and straightening.<span class="citation"><sup>[<a href="#ref-ballotta2005" role="doc-biblioref">77</a>]</sup></span></p></li>
<li><p>Fibromuscular Dysplasia (FMD)<span class="citation"><sup>[<a href="#ref-olin2011" role="doc-biblioref">78</a>]</sup></span> - for more, see
<a href="renal.html#fibromuscular-dysplasia-fmd">7.4</a></p>
<ul>
<li><p>Asymptomatic disease can often be treated with antiplatelets
alone.</p></li>
<li><p>Duplex ultrasound demonstrates classic “chain of lakes”
appearance. For more see <a href="vascular-lab.html#extracranial">12.2</a></p></li>
<li><p>Associated with intracranial aneurysms (13%), therefore may be
reasonable to also pursue brain imaging if identified. However,
no formal guidelines exist.<span class="citation"><sup>[<a href="#ref-lather2017" role="doc-biblioref">79</a>]</sup></span></p></li>
</ul></li>
</ul>
</div>
<div id="carotid-body-tumors-cbt" class="section level3 hasAnchor" number="2.4.5">
<h3><span class="header-section-number">2.4.5</span> Carotid Body Tumors (CBT)<a href="cerebrovascular.html#carotid-body-tumors-cbt" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Shamblin criteria utilized to determine difficulty of resection and is
associated with rates of carotid reconstruction or cranial nerve injury.</p>
<p>Blood supply primarily from the external carotid artery.<span class="citation"><sup>[<a href="#ref-robertson2019" role="doc-biblioref">80</a>,<a href="#ref-davila2016" role="doc-biblioref">81</a>]</sup></span> Embolization helps reduce risk of perioperative blood loss
not associated with reduced cranial nerve injury.  Resection 24-36hrs
after embolization.<span class="citation"><sup>[<a href="#ref-power2012" role="doc-biblioref">82</a>]</sup></span></p>
<p>One quarter (25%) are associated with a germline mutation or familial
history. Genetic testing recommended in patients with multifocal tumors,
associated paraganglioma, pheochromocytoma or family history.  SDHD gene
mutation is most common associated with familial
paraganglioma.<span class="citation"><sup>[<a href="#ref-davila2016" role="doc-biblioref">81</a>,<a href="#ref-kruger2010" role="doc-biblioref">83</a>]</sup></span></p>
<p>Evaluating for carotid body ligation - When involved with a CBT or other
skull base tumors, cerebral perfusion should be thoroughly evaluated
prior to surgical resection to determine whether a patient will tolerate
carotid ligation. Evaluation includes balloon occlusion testing with
xenon-enhanced SPECT imaging. Low risk for ligation if no neurologic
deficits (after 30min and hypotensive challenge) and normal diffusion of
SPECT (ratio of &gt;0.9).  Angiography with contralateral occlusion
evaluates collaterals.<span class="citation"><sup>[<a href="#ref-sugawara" role="doc-biblioref">84</a>,<a href="#ref-tansavatdi2015" role="doc-biblioref">85</a>]</sup></span></p>

</div>
</div>
</div>
<h3>References<a href="references.html#references" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="refs" class="references csl-bib-body hanging-indent" line-spacing="2">
<div id="ref-aburahmaSocietyVascularSurgery2022" class="csl-entry">
1. AbuRahma, A. F., Avgerinos, E. D., Chang, R. W., Darling, R. C., Duncan, A. A., Forbes, T. L., Malas, M. B., Murad, M. H., Perler, B. A., Powell, R. J., Rockman, C. B., &amp; Zhou, W. (2022). Society for <span>Vascular Surgery</span> clinical practice guidelines for management of extracranial cerebrovascular disease. <em>Journal of Vascular Surgery</em>, <em>75</em>(1), 4S–22S. <a href="https://doi.org/10.1016/j.jvs.2021.04.073">https://doi.org/10.1016/j.jvs.2021.04.073</a>
</div>
<div id="ref-fischer2010" class="csl-entry">
2. Fischer, U., Baumgartner, A., Arnold, M., Nedeltchev, K., Gralla, J., Marco De Marchis, G., Kappeler, L., Mono, M.-L., Brekenfeld, C., Schroth, G., &amp; al., et. (2010). What is a minor stroke? <em>Stroke</em>, <em>41</em>(4), 661–666. <a href="https://doi.org/10.1161/STROKEAHA.109.572883">https://doi.org/10.1161/STROKEAHA.109.572883</a>
</div>
<div id="ref-ricotta" class="csl-entry">
3. Ricotta, J. J. (n.d.). 89. Cerebrovascular disease: Decision making including medical therapy. In <em>Rutherford’s vascular surgery and endovascular therapy</em> (p. 20).
</div>
<div id="ref-rockman2019" class="csl-entry">
4. Rockman, C. B. (2019). 86. Cerebrovascular disease: Epidemiology and natural history. In <em>Rutherford’s vascular surgery and endovascular theapy</em> (p. 25). Elsevier Inc.
</div>
<div id="ref-aburahma2022" class="csl-entry">
5. AbuRahma, A. F., &amp; Perler, B. A. (2022). <em>Noninvasive vascular diagnosis: A practical textbook for clinicians</em>.
</div>
<div id="ref-shaalan2008" class="csl-entry">
6. Shaalan, W. E., Wahlgren, C. M., Desai, T., Piano, G., Skelly, C., &amp; Bassiouny, H. S. (2008). Reappraisal of velocity criteria for carotid bulb/internal carotid artery stenosis utilizing high-resolution b-mode ultrasound validated with computed tomography angiography. <em>Journal of Vascular Surgery</em>, <em>48</em>(1), 104–113. <a href="https://doi.org/10.1016/j.jvs.2008.02.068">https://doi.org/10.1016/j.jvs.2008.02.068</a>
</div>
<div id="ref-naylorWhyManagementAsymptomatic2015" class="csl-entry">
7. Naylor, A. R. (2015). Why is the management of asymptomatic carotid disease so controversial? <em>The Surgeon</em>, <em>13</em>(1), 34–43. <a href="https://doi.org/10.1016/j.surge.2014.08.004">https://doi.org/10.1016/j.surge.2014.08.004</a>
</div>
<div id="ref-bulbuliaAsymptomaticCarotidSurgery2017" class="csl-entry">
8. Bulbulia, R., &amp; Halliday, A. (2017). The <span>Asymptomatic Carotid Surgery Trial-2</span> (<span>ACST-2</span>): An ongoing randomised controlled trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke. <em>Health Technology Assessment</em>, <em>21</em>(57), 1–40. <a href="https://doi.org/10.3310/hta21570">https://doi.org/10.3310/hta21570</a>
</div>
<div id="ref-rosenfieldRandomizedTrialStent2016" class="csl-entry">
10. Rosenfield, K., Matsumura, J. S., Chaturvedi, S., Riles, T., Ansel, G. M., Metzger, D. C., Wechsler, L., Jaff, M. R., &amp; Gray, W. (2016). Randomized <span>Trial</span> of <span>Stent</span> versus <span>Surgery</span> for <span>Asymptomatic Carotid Stenosis</span>. <em>New England Journal of Medicine</em>, <em>374</em>(11), 1011–1020. <a href="https://doi.org/10.1056/NEJMoa1515706">https://doi.org/10.1056/NEJMoa1515706</a>
</div>
<div id="ref-aiyagari2009" class="csl-entry">
11. Aiyagari, V., &amp; Gorelick, P. B. (2009). Management of blood pressure for acute and recurrent stroke. <em>Stroke</em>, <em>40</em>(6), 2251–2256. <a href="https://doi.org/10.1161/STROKEAHA.108.531574">https://doi.org/10.1161/STROKEAHA.108.531574</a>
</div>
<div id="ref-karamHighDoseAtorvastatinStroke2008" class="csl-entry">
12. Karam, J. G., Loney-Hutchinson, L., &amp; McFarlane, S. I. (2008). High-<span>Dose Atorvastatin After Stroke</span> or <span>Transient Ischemic Attack</span>: <span>The Stroke Prevention</span> by <span>Aggressive Reduction</span> in <span>Cholesterol Levels</span> (<span>SPARCL</span>) <span>Investigators</span>. <em>Journal of the CardioMetabolic Syndrome</em>, <em>3</em>(1), 68–69. <a href="https://doi.org/10.1111/j.1559-4572.2008.07967.x">https://doi.org/10.1111/j.1559-4572.2008.07967.x</a>
</div>
<div id="ref-hicks2015" class="csl-entry">
13. Hicks, C. W., Talbott, K., Canner, J. K., Qazi, U., Arhuidese, I., Glebova, N. O., Freischlag, J. A., Perler, B. A., &amp; Malas, M. B. (2015). Risk of disease progression in patients with moderate asymptomatic carotid artery stenosis: Implications of tobacco use and dual antiplatelet therapy. <em>Annals of Vascular Surgery</em>, <em>29</em>(1), 1–8. <a href="https://doi.org/10.1016/j.avsg.2014.02.007">https://doi.org/10.1016/j.avsg.2014.02.007</a>
</div>
<div id="ref-wilson1997" class="csl-entry">
16. Wilson, P. W., Hoeg, J. M., D’Agostino, R. B., Silbershatz, H., Belanger, A. M., Poehlmann, H., O’Leary, D., &amp; Wolf, P. A. (1997). Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. <em>The New England Journal of Medicine</em>, <em>337</em>(8), 516–522. <a href="https://doi.org/10.1056/NEJM199708213370802">https://doi.org/10.1056/NEJM199708213370802</a>
</div>
<div id="ref-powers2018GuidelinesEarly2018" class="csl-entry">
17. Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., &amp; Tirschwell, D. L. (2018). 2018 <span>Guidelines</span> for the <span>Early Management</span> of <span>Patients With Acute Ischemic Stroke</span>: <span>A Guideline</span> for <span>Healthcare Professionals From</span> the <span>American Heart Association</span>/<span>American Stroke Association</span>. <em>Stroke</em>, <em>49</em>(3). <a href="https://doi.org/10.1161/STR.0000000000000158">https://doi.org/10.1161/STR.0000000000000158</a>
</div>
<div id="ref-rothwellEndarterectomySymptomaticCarotid2004" class="csl-entry">
18. Rothwell, P., Eliasziw, M., Gutnikov, S., Warlow, C., &amp; Barnett, H. (2004). Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. <em>The Lancet</em>, <em>363</em>(9413), 915–924. <a href="https://doi.org/10.1016/S0140-6736(04)15785-1">https://doi.org/10.1016/S0140-6736(04)15785-1</a>
</div>
<div id="ref-meershoekTimingCarotidIntervention2018" class="csl-entry">
19. Meershoek, A. J. A., &amp; de Borst, G. J. (2018). Timing of carotid intervention. <em>The British Journal of Surgery</em>, <em>105</em>(10), 1231–1233. <a href="https://doi.org/10.1002/bjs.10950">https://doi.org/10.1002/bjs.10950</a>
</div>
<div id="ref-rantnerEarlyEndarterectomyCarries2017" class="csl-entry">
20. Rantner, B., Kollerits, B., Roubin, G. S., Ringleb, P. A., Jansen, O., Howard, G., Hendrikse, J., Halliday, A., Gregson, J., Eckstein, H.-H., Calvet, D., Bulbulia, R., Bonati, L. H., Becquemin, J.-P., Algra, A., Brown, M. M., Mas, J.-L., Brott, T. G., &amp; Fraedrich, G. (2017). Early <span>Endarterectomy Carries</span> a <span>Lower Procedural Risk Than Early Stenting</span> in <span>Patients With Symptomatic Stenosis</span> of the <span>Internal Carotid Artery</span>. <em>Stroke</em>, <em>48</em>, 1580–1587. <a href="https://doi.org/10.1161/STROKEAHA.116.016233">https://doi.org/10.1161/STROKEAHA.116.016233</a>
</div>
<div id="ref-goodney2010" class="csl-entry">
21. Goodney, P. P., Nolan, B. W., Eldrup-Jorgensen, J., Likosky, D. S., &amp; Cronenwett, J. L. (2010). Restenosis after carotid endarterectomy in a multicenter regional registry. <em>Journal of Vascular Surgery</em>, <em>52</em>(4), 897–905.e2. <a href="https://doi.org/10.1016/j.jvs.2010.05.005">https://doi.org/10.1016/j.jvs.2010.05.005</a>
</div>
<div id="ref-rerkasem2009" class="csl-entry">
22. Rerkasem, K., &amp; Rothwell, P. M. (2009). Patch angioplasty versus primary closure for carotid endarterectomy. <em>The Cochrane Database of Systematic Reviews</em>, <em>2009</em>(4), CD000160. <a href="https://doi.org/10.1002/14651858.CD000160.pub3">https://doi.org/10.1002/14651858.CD000160.pub3</a>
</div>
<div id="ref-arnold2019" class="csl-entry">
23. Arnold, M., &amp; Perler, B. A. (2019). 91. Carotid endarterectomy. In <em>Rutherford’s vascular surgery and endovascular therapy</em>. Elsevier Inc.
</div>
<div id="ref-chongruksut2014" class="csl-entry">
24. Chongruksut, W., Vaniyapong, T., &amp; Rerkasem, K. (2014). Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting). <em>The Cochrane Database of Systematic Reviews</em>, <em>2014</em>(6), CD000190. <a href="https://doi.org/10.1002/14651858.CD000190.pub3">https://doi.org/10.1002/14651858.CD000190.pub3</a>
</div>
<div id="ref-wiske2018" class="csl-entry">
25. Wiske, C., Arhuidese, I., Malas, M., &amp; Patterson, R. (2018). Comparing the efficacy of shunting approaches and cerebral monitoring during carotid endarterectomy using a national database. <em>Journal of Vascular Surgery</em>, <em>68</em>(2), 416–425. <a href="https://doi.org/10.1016/j.jvs.2017.11.077">https://doi.org/10.1016/j.jvs.2017.11.077</a>
</div>
<div id="ref-moritz2007" class="csl-entry">
26. Moritz, S., Kasprzak, P., Arlt, M., Taeger, K., &amp; Metz, C. (2007). Accuracy of cerebral monitoring in detecting cerebral ischemia during carotid endarterectomy: A comparison of transcranial doppler sonography, near-infrared spectroscopy, stump pressure, and somatosensory evoked potentials. <em>Anesthesiology</em>, <em>107</em>(4), 563–569. <a href="https://doi.org/10.1097/01.anes.0000281894.69422.ff">https://doi.org/10.1097/01.anes.0000281894.69422.ff</a>
</div>
<div id="ref-beretta2006" class="csl-entry">
27. Beretta, F., Hemida, S. A., Andaluz, N., Zuccarello, M., &amp; Keller, J. T. (2006). Exposure of the cervical internal carotid artery: Surgical steps to the cranial base and morphometric study. <em>Neurosurgery</em>, <em>59</em>(1 Suppl 1), ONS25-34; discussion ONS25-34. <a href="https://doi.org/10.1227/01.NEU.0000219877.43072.49">https://doi.org/10.1227/01.NEU.0000219877.43072.49</a>
</div>
<div id="ref-lipski1996" class="csl-entry">
28. Lipski, D. A., Bergamini, T. M., Garrison, R. N., &amp; Fulton, R. L. (1996). Intraoperative duplex scanning reduces the incidence of residual stenosis after carotid endarterectomy. <em>The Journal of Surgical Research</em>, <em>60</em>(2), 317–320. <a href="https://doi.org/10.1006/jsre.1996.0050">https://doi.org/10.1006/jsre.1996.0050</a>
</div>
<div id="ref-weinstein2015" class="csl-entry">
29. Weinstein, S., Mabray, M. C., Aslam, R., Hope, T., Yee, J., &amp; Owens, C. (2015). Intraoperative sonography during carotid endarterectomy: Normal appearance and spectrum of complications. <em>Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine</em>, <em>34</em>(5), 885–894. <a href="https://doi.org/10.7863/ultra.34.5.885">https://doi.org/10.7863/ultra.34.5.885</a>
</div>
<div id="ref-ricco2013" class="csl-entry">
30. Ricco, J.-B., Schneider, F., Illuminati, G., &amp; Samson, R. H. (2013). The role of completion imaging following carotid artery endarterectomy. <em>Journal of Vascular Surgery</em>, <em>57</em>(5), 1432–1438. <a href="https://doi.org/10.1016/j.jvs.2013.02.001">https://doi.org/10.1016/j.jvs.2013.02.001</a>
</div>
<div id="ref-ascher2004" class="csl-entry">
31. Ascher, E., Markevich, N., Kallakuri, S., Schutzer, R. W., &amp; Hingorani, A. P. (2004). Intraoperative carotid artery duplex scanning in a modern series of 650 consecutive primary endarterectomy procedures. <em>Journal of Vascular Surgery</em>, <em>39</em>(2), 416–420. <a href="https://doi.org/10.1016/j.jvs.2003.09.019">https://doi.org/10.1016/j.jvs.2003.09.019</a>
</div>
<div id="ref-fletcher2016" class="csl-entry">
32. Fletcher, E., Kabeer, M., Sathianathan, J., Muir, I., Williams, D., &amp; Lim, C. (2016). Immediate catheter directed thrombolysis for thromboembolic stroke during carotid endarterectomy. <em>EJVES Short Reports</em>, <em>31</em>, 12–15. <a href="https://doi.org/10.1016/j.ejvssr.2016.03.003">https://doi.org/10.1016/j.ejvssr.2016.03.003</a>
</div>
<div id="ref-kaku2004" class="csl-entry">
33. Kaku, Y., Yoshimura, S., &amp; Kokuzawa, J. (2004). Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. <em>AJNR: American Journal of Neuroradiology</em>, <em>25</em>(8), 1403–1408. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975476/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975476/</a>
</div>
<div id="ref-abou-chebl2004" class="csl-entry">
34. Abou-Chebl, A., Yadav, J. S., Reginelli, J. P., Bajzer, C., Bhatt, D., &amp; Krieger, D. W. (2004). Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: Risk factors, prevention, and treatment. <em>Journal of the American College of Cardiology</em>, <em>43</em>(9), 1596–1601. <a href="https://doi.org/10.1016/j.jacc.2003.12.039">https://doi.org/10.1016/j.jacc.2003.12.039</a>
</div>
<div id="ref-klarinPerioperativeLongtermImpact2016" class="csl-entry">
35. Klarin, D., Lancaster, R. T., Ergul, E., Bertges, D., Goodney, P., Schermerhorn, M. L., Cambria, R. P., &amp; Patel, V. I. (2016). Perioperative and long-term impact of chronic kidney disease on carotid artery interventions. <em>Journal of Vascular Surgery</em>, <em>64</em>(5), 1295–1302. <a href="https://doi.org/10.1016/j.jvs.2016.04.038">https://doi.org/10.1016/j.jvs.2016.04.038</a>
</div>
<div id="ref-kang2014" class="csl-entry">
36. Kang, J., Conrad, M. F., Patel, V. I., Mukhopadhyay, S., Garg, A., Cambria, M. R., LaMuraglia, G. M., &amp; Cambria, R. P. (2014). Clinical and anatomic outcomes after carotid endarterectomy. <em>Journal of Vascular Surgery</em>, <em>59</em>(4), 944–949. <a href="https://doi.org/10.1016/j.jvs.2013.10.059">https://doi.org/10.1016/j.jvs.2013.10.059</a>
</div>
<div id="ref-garzon-muvdi2016" class="csl-entry">
37. Garzon-Muvdi, T., Yang, W., Rong, X., Caplan, J. M., Ye, X., Colby, G. P., Coon, A. L., Tamargo, R. J., &amp; Huang, J. (2016). Restenosis after carotid endarterectomy: Insight into risk factors and modification of postoperative management. <em>World Neurosurgery</em>, <em>89</em>, 159–167. <a href="https://doi.org/10.1016/j.wneu.2016.01.028">https://doi.org/10.1016/j.wneu.2016.01.028</a>
</div>
<div id="ref-stone2011" class="csl-entry">
38. Stone, P. A., Srivastava, M., Campbell, J. E., Mousa, A. Y., Hass, S. H., Kazmi, H., Dearing, D. D., &amp; AbuRahma, A. F. (2011). A 10-year experience of infection following carotid endarterectomy with patch angioplasty. <em>Journal of Vascular Surgery</em>, <em>53</em>(6), 1473–1477. <a href="https://doi.org/10.1016/j.jvs.2011.02.020">https://doi.org/10.1016/j.jvs.2011.02.020</a>
</div>
<div id="ref-fatima2019" class="csl-entry">
39. Fatima, J., Federico, V. P., Scali, S. T., Feezor, R. J., Berceli, S. A., Giles, K. A., Arnaoutakis, D. J., Back, M. R., Upchurch, G. R., &amp; Huber, T. S. (2019). Management of patch infections after carotid endarterectomy and utility of femoral vein interposition bypass graft. <em>Journal of Vascular Surgery</em>, <em>69</em>(6), 1815–1823.e1. <a href="https://doi.org/10.1016/j.jvs.2018.09.036">https://doi.org/10.1016/j.jvs.2018.09.036</a>
</div>
<div id="ref-giannopoulosRevascularizationRadiationinducedCarotid2018" class="csl-entry">
40. Giannopoulos, S., Texakalidis, P., Jonnalagadda, A. K., Karasavvidis, T., Giannopoulos, S., &amp; Kokkinidis, D. G. (2018). Revascularization of radiation-induced carotid artery stenosis with carotid endarterectomy vs. Carotid artery stenting: <span>A</span> systematic review and meta-analysis. <em>Cardiovascular Revascularization Medicine</em>, <em>19</em>(5), 638–644. <a href="https://doi.org/10.1016/j.carrev.2018.01.014">https://doi.org/10.1016/j.carrev.2018.01.014</a>
</div>
<div id="ref-kwolek2015" class="csl-entry">
41. Kwolek, C. J., Jaff, M. R., Leal, J. I., Hopkins, L. N., Shah, R. M., Hanover, T. M., Macdonald, S., Cambria, R. P., Flores, A., Leal, I., &amp; al., et. (2015). Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. <em>Journal of Vascular Surgery</em>, <em>62</em>(5), 1227–1234.e1. <a href="https://doi.org/10.1016/j.jvs.2015.04.460">https://doi.org/10.1016/j.jvs.2015.04.460</a>
</div>
<div id="ref-brott2010" class="csl-entry">
42. Brott, T. G., Hobson, R. W., Howard, G., Roubin, G. S., Clark, W. M., Brooks, W., Mackey, A., Hill, M. D., Leimgruber, P. P., Sheffet, A. J., &amp; al., et. (2010). Stenting versus endarterectomy for treatment of carotid-artery stenosis. <em>The New England Journal of Medicine</em>, <em>363</em>(1), 11–23. <a href="https://doi.org/10.1056/NEJMoa0912321">https://doi.org/10.1056/NEJMoa0912321</a>
</div>
<div id="ref-valls2017" class="csl-entry">
43. Valls, J., Peiro-Chamarro, M., Cambray, S., Molina-Seguin, J., Benabdelhak, I., &amp; Purroy, F. (2017). A current estimation of the early risk of stroke after transient ischemic attack: A systematic review and meta-analysis of recent intervention studies. <em>Cerebrovascular Diseases (Basel, Switzerland)</em>, <em>43</em>(1-2), 90–98. <a href="https://doi.org/10.1159/000452978">https://doi.org/10.1159/000452978</a>
</div>
<div id="ref-plessers2016" class="csl-entry">
44. Plessers, M., Van Herzeele, I., Hemelsoet, D., Patel, N., Chung, E. M. L., Vingerhoets, G., &amp; Vermassen, F. (2016). Transcervical carotid stenting with dynamic flow reversal demonstrates embolization rates comparable to carotid endarterectomy. <em>Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists</em>, <em>23</em>(2), 249–254. <a href="https://doi.org/10.1177/1526602815626561">https://doi.org/10.1177/1526602815626561</a>
</div>
<div id="ref-coelho2019" class="csl-entry">
45. Coelho, A. P., Lobo, M., Nogueira, C., Gouveia, R., Campos, J., Augusto, R., Coelho, N., Semião, A. C., &amp; Canedo, A. (2019). Overview of evidence on risk factors and early management of acute carotid stent thrombosis during the last two decades. <em>Journal of Vascular Surgery</em>, <em>69</em>(3), 952–964. <a href="https://doi.org/10.1016/j.jvs.2018.09.053">https://doi.org/10.1016/j.jvs.2018.09.053</a>
</div>
<div id="ref-naylor2018" class="csl-entry">
46. Naylor, A. R., Ricco, J.-B., Borst, G. J. de, Debus, S., Haro, J. de, Halliday, A., Hamilton, G., Kakisis, J., Kakkos, S., Lepidi, S., &amp; al., et. (2018). Editor’s choice - management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the european society for vascular surgery (ESVS). <em>European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery</em>, <em>55</em>(1), 3–81. <a href="https://doi.org/10.1016/j.ejvs.2017.06.021">https://doi.org/10.1016/j.ejvs.2017.06.021</a>
</div>
<div id="ref-clavel2019" class="csl-entry">
47. Clavel, P., Hebert, S., Saleme, S., Mounayer, C., Rouchaud, A., &amp; Marin, B. (2019). Cumulative incidence of restenosis in the endovascular treatment of extracranial carotid artery stenosis: A meta-analysis. <em>Journal of Neurointerventional Surgery</em>, <em>11</em>(9), 916–923. <a href="https://doi.org/10.1136/neurintsurg-2018-014534">https://doi.org/10.1136/neurintsurg-2018-014534</a>
</div>
<div id="ref-arhuidese2017" class="csl-entry">
48. Arhuidese, I. J., Nejim, B., Chavali, S., Locham, S., Obeid, T., Hicks, C. W., &amp; Malas, M. B. (2017). Endarterectomy versus stenting in patients with prior ipsilateral carotid artery stenting. <em>Journal of Vascular Surgery</em>, <em>65</em>(5), 1418–1428. <a href="https://doi.org/10.1016/j.jvs.2016.11.041">https://doi.org/10.1016/j.jvs.2016.11.041</a>
</div>
<div id="ref-chungPercutaneousInterventionCarotid2016a" class="csl-entry">
49. Chung, J., Valentine, W., Sharath, S. E., Pathak, A., Barshes, N. R., Pisimisis, G., Kougias, P., &amp; Mills, J. L. (2016). Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management. <em>Journal of Vascular Surgery</em>, <em>64</em>(5), 1286–1294.e1. <a href="https://doi.org/10.1016/j.jvs.2016.05.086">https://doi.org/10.1016/j.jvs.2016.05.086</a>
</div>
<div id="ref-northamericansymptomaticcarotidendarterectomytrialcollaboratorsBeneficialEffectCarotid1991" class="csl-entry">
50. North American Symptomatic Carotid Endarterectomy Trial Collaborators. (1991). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. <em>New England Journal of Medicine</em>, <em>325</em>(7), 445–453. <a href="https://doi.org/10.1056/NEJM199108153250701">https://doi.org/10.1056/NEJM199108153250701</a>
</div>
<div id="ref-silver2011" class="csl-entry">
51. Silver, F. L., Mackey, A., Clark, W. M., Brooks, W., Timaran, C. H., Chiu, D., Goldstein, L. B., Meschia, J. F., Ferguson, R. D., Moore, W. S., &amp; al., et. (2011). Safety of stenting and endarterectomy by symptomatic status in the carotid revascularization endarterectomy vs. Stenting trial (CREST). <em>Stroke; a Journal of Cerebral Circulation</em>, <em>42</em>(3), 675–680. <a href="https://doi.org/10.1161/STROKEAHA.110.610212">https://doi.org/10.1161/STROKEAHA.110.610212</a>
</div>
<div id="ref-brottLongTermResultsStenting2016b" class="csl-entry">
52. Brott, T. G., Howard, G., Roubin, G. S., Meschia, J. F., Mackey, A., Brooks, W., Moore, W. S., Hill, M. D., Mantese, V. A., Clark, W. M., Timaran, C. H., Heck, D., Leimgruber, P. P., Sheffet, A. J., Howard, V. J., Chaturvedi, S., Lal, B. K., Voeks, J. H., &amp; Hobson, R. W. (2016). Long-<span>Term Results</span> of <span>Stenting</span> versus <span>Endarterectomy</span> for <span>Carotid-Artery Stenosis</span>. <em>The New England Journal of Medicine</em>, <em>374</em>(11), 1021–1031. <a href="https://doi.org/10.1056/NEJMoa1505215">https://doi.org/10.1056/NEJMoa1505215</a>
</div>
<div id="ref-redfern2011" class="csl-entry">
53. Redfern, G., Rodseth, R. N., &amp; Biccard, B. M. (2011). Outcomes in vascular surgical patients with isolated postoperative troponin leak: A meta-analysis: Troponin leak in vascular surgical patients. <em>Anaesthesia</em>, <em>66</em>(7), 604–610. <a href="https://doi.org/10.1111/j.1365-2044.2011.06763.x">https://doi.org/10.1111/j.1365-2044.2011.06763.x</a>
</div>
<div id="ref-mantese2010" class="csl-entry">
54. Mantese, V. A., Timaran, C. H., Chiu, D., Begg, R. J., &amp; Brott, T. G. (2010). The carotid revascularization endarterectomy versus stenting trial (CREST) - stenting versus carotid endarterectomy for carotid disease. <em>Stroke; a Journal of Cerebral Circulation</em>, <em>41</em>(10 Suppl), S31–S34. <a href="https://doi.org/10.1161/STROKEAHA.110.595330">https://doi.org/10.1161/STROKEAHA.110.595330</a>
</div>
<div id="ref-hrbác2012" class="csl-entry">
55. Hrbáč, T., Beneš, V., Širůček, P., Jonszta, T., Herzig, R., Procházka, V., &amp; Skoloudík, D. (2012). Safety and efficacy of surgical treatment of carotid stump syndrome: Pilot study. <em>Annals of Vascular Surgery</em>, <em>26</em>(6), 797–801. <a href="https://doi.org/10.1016/j.avsg.2011.11.034">https://doi.org/10.1016/j.avsg.2011.11.034</a>
</div>
<div id="ref-naylorSystematicReviewOutcomes2003" class="csl-entry">
56. Naylor, A. R., Cuffe, R. L., Rothwell, P. M., &amp; Bell, P. R. F. (2003). A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>25</em>(5), 380–389. <a href="https://doi.org/10.1053/ejvs.2002.1895">https://doi.org/10.1053/ejvs.2002.1895</a>
</div>
<div id="ref-chimowitz2011" class="csl-entry">
57. Chimowitz, M. I., Lynn, M. J., Derdeyn, C. P., Turan, T. N., Fiorella, D., Lane, B. F., Janis, L. S., Lutsep, H. L., Barnwell, S. L., Waters, M. F., &amp; al., et. (2011). Stenting versus aggressive medical therapy for intracranial arterial stenosis. <em>The New England Journal of Medicine</em>, <em>365</em>(11), 993–1003. <a href="https://doi.org/10.1056/NEJMoa1105335">https://doi.org/10.1056/NEJMoa1105335</a>
</div>
<div id="ref-ec/icbypassstudygroup1985" class="csl-entry">
58. Group, E. B. S. (1985). Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. <em>The New England Journal of Medicine</em>, <em>313</em>(19), 1191–1200. <a href="https://doi.org/10.1056/NEJM198511073131904">https://doi.org/10.1056/NEJM198511073131904</a>
</div>
<div id="ref-limanetoPathophysiologyDiagnosisVertebrobasilar2017" class="csl-entry">
59. Lima Neto, A. C., Bittar, R., Gattas, G. S., Bor-Seng-Shu, E., Oliveira, M. de L., Monsanto, R. da C., &amp; Bittar, L. F. (2017). Pathophysiology and <span>Diagnosis</span> of <span>Vertebrobasilar Insufficiency</span>: <span>A Review</span> of the <span>Literature</span>. <em>International Archives of Otorhinolaryngology</em>, <em>21</em>(3), 302–307. <a href="https://doi.org/10.1055/s-0036-1593448">https://doi.org/10.1055/s-0036-1593448</a>
</div>
<div id="ref-nouh2014" class="csl-entry">
60. Nouh, A., Remke, J., &amp; Ruland, S. (2014). Ischemic posterior circulation stroke: A review of anatomy, clinical presentations, diagnosis, and current management. <em>Frontiers in Neurology</em>, <em>5</em>, 30. <a href="https://doi.org/10.3389/fneur.2014.00030">https://doi.org/10.3389/fneur.2014.00030</a>
</div>
<div id="ref-limaneto2017" class="csl-entry">
61. Lima Neto, A. C., Bittar, R., Gattas, G. S., Bor-Seng-Shu, E., Oliveira, M. de L., Monsanto, R. da C., &amp; Bittar, L. F. (2017). Pathophysiology and diagnosis of vertebrobasilar insufficiency: A review of the literature. <em>International Archives of Otorhinolaryngology</em>, <em>21</em>(3), 302–307. <a href="https://doi.org/10.1055/s-0036-1593448">https://doi.org/10.1055/s-0036-1593448</a>
</div>
<div id="ref-morasch2019" class="csl-entry">
62. Morasch, M. (2019). 97. Vertebral artery dissection and other conditions. In <em>Rutherford’s vascular surgery and endovascular therapy</em> (p. 18). Elsevier Inc.
</div>
<div id="ref-berguer1998" class="csl-entry">
63. Berguer, R., Morasch, M. D., &amp; Kline, R. A. (1998). Transthoracic repair of innominate and common carotid artery disease: Immediate and long-term outcome for 100 consecutive surgical reconstructions. <em>Journal of Vascular Surgery</em>, <em>27</em>(1), 34–41; discussion 42. <a href="https://doi.org/10.1016/s0741-5214(98)70289-7">https://doi.org/10.1016/s0741-5214(98)70289-7</a>
</div>
<div id="ref-rangel-castilla2015" class="csl-entry">
64. Rangel-Castilla, L., Kalani, M. Y. S., Cronk, K., Zabramski, J. M., Russin, J. J., &amp; Spetzler, R. F. (2015). Vertebral artery transposition for revascularization of the posterior circulation: A critical assessment of temporary and permanent complications and outcomes. <em>Journal of Neurosurgery</em>, <em>122</em>(3), 671–677. <a href="https://doi.org/10.3171/2014.9.JNS14194">https://doi.org/10.3171/2014.9.JNS14194</a>
</div>
<div id="ref-coleman2013" class="csl-entry">
65. Coleman, D. M., Obi, A., Criado, E., Arya, S., &amp; Berguer, R. (2013). Contemporary outcomes after distal vertebral reconstruction. <em>Journal of Vascular Surgery</em>, <em>58</em>(1), 152–157. <a href="https://doi.org/10.1016/j.jvs.2012.12.067">https://doi.org/10.1016/j.jvs.2012.12.067</a>
</div>
<div id="ref-ramirez2012" class="csl-entry">
66. Ramirez, C. A., Febrer, G., Gaudric, J., Abou-Taam, S., Beloucif, K., Chiche, L., &amp; Koskas, F. (2012). Open repair of vertebral artery: A 7-year single-center report. <em>Annals of Vascular Surgery</em>, <em>26</em>(1), 79–85. <a href="https://doi.org/10.1016/j.avsg.2011.09.001">https://doi.org/10.1016/j.avsg.2011.09.001</a>
</div>
<div id="ref-berguer1985" class="csl-entry">
67. Berguer, R. (1985). Distal vertebral artery bypass: Technique, the <span>“occipital connection,”</span> and potential uses. <em>Journal of Vascular Surgery</em>, <em>2</em>(4), 621–626.
</div>
<div id="ref-antoniou2012" class="csl-entry">
68. Antoniou, G. A., Murray, D., Georgiadis, G. S., Antoniou, S. A., Schiro, A., Serracino-Inglott, F., &amp; Smyth, J. V. (2012). Percutaneous transluminal angioplasty and stenting in patients with proximal vertebral artery stenosis. <em>Journal of Vascular Surgery</em>, <em>55</em>(4), 1167–1177. <a href="https://doi.org/10.1016/j.jvs.2011.09.084">https://doi.org/10.1016/j.jvs.2011.09.084</a>
</div>
<div id="ref-coward2007" class="csl-entry">
69. Coward, L. J., McCabe, D. J. H., Ederle, J., Featherstone, R. L., Clifton, A., Brown, M. M., &amp; Investigators, C. (2007). Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): A randomized trial. <em>Stroke</em>, <em>38</em>(5), 1526–1530. <a href="https://doi.org/10.1161/STROKEAHA.106.471862">https://doi.org/10.1161/STROKEAHA.106.471862</a>
</div>
<div id="ref-cohenSinglecenterExperienceEndovascular2012" class="csl-entry">
70. Cohen, J. E., Gomori, J. M., Itshayek, E., Spektor, S., Shoshan, Y., Rosenthal, G., &amp; Moscovici, S. (2012). Single-center experience on endovascular reconstruction of traumatic internal carotid artery dissections: <em>The Journal of Trauma and Acute Care Surgery</em>, <em>72</em>(1), 216–221. <a href="https://doi.org/10.1097/TA.0b013e31823f630a">https://doi.org/10.1097/TA.0b013e31823f630a</a>
</div>
<div id="ref-phamEndovascularStentingExtracranial2011" class="csl-entry">
72. Pham, M. H., Rahme, R. J., Arnaout, O., Hurley, M. C., Bernstein, R. A., Batjer, H. H., &amp; Bendok, B. R. (2011). Endovascular <span>Stenting</span> of <span>Extracranial Carotid</span> and <span>Vertebral Artery Dissections</span>: <span>A Systematic Review</span> of the <span>Literature</span>. <em>Neurosurgery</em>, <em>68</em>(4), 856–866. <a href="https://doi.org/10.1227/NEU.0b013e318209ce03">https://doi.org/10.1227/NEU.0b013e318209ce03</a>
</div>
<div id="ref-bush2019" class="csl-entry">
73. Bush, R. L., Long, P., &amp; Atkins, M. D. (2019). 94. Carotid artery aneurysms. In <em>Rutherford’s vascular surgery and endovascular therapy, 2-volume set</em> (pp. 1242–1254e). Elsevier Inc. <a href="https://doi.org/10.1016/B978-0-323-42791-3.00094-3">https://doi.org/10.1016/B978-0-323-42791-3.00094-3</a>
</div>
<div id="ref-pourier2018" class="csl-entry">
75. Pourier, V. E. C., Welleweerd, J. C., Kappelle, L. J., Rinkel, G. J. E., Ruigrok, Y. M., Worp, H. B. van der, Lo, T. H., Bots, M. L., Moll, F. L., &amp; Borst, G. J. de. (2018). Experience of a single center in the conservative approach of 20 consecutive cases of asymptomatic extracranial carotid artery aneurysms. <em>European Journal of Neurology</em>, <em>25</em>(10), 1285–1289. <a href="https://doi.org/10.1111/ene.13720">https://doi.org/10.1111/ene.13720</a>
</div>
<div id="ref-welleweerd2015" class="csl-entry">
76. Welleweerd, J. C., Ruijter, H. M. den, Nelissen, B. G. L., Bots, M. L., Kappelle, L. J., Rinkel, G. J. E., Moll, F. L., &amp; Borst, G. J. de. (2015). Management of extracranial carotid artery aneurysm. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>50</em>(2), 141–147. <a href="https://doi.org/10.1016/j.ejvs.2015.05.002">https://doi.org/10.1016/j.ejvs.2015.05.002</a>
</div>
<div id="ref-ballotta2005" class="csl-entry">
77. Ballotta, E., Thiene, G., Baracchini, C., Ermani, M., Militello, C., Da Giau, G., Barbon, B., &amp; Angelini, A. (2005). Surgical vs medical treatment for isolated internal carotid artery elongation with coiling or kinking in symptomatic patients: A prospective randomized clinical study. <em>Journal of Vascular Surgery</em>, <em>42</em>(5), 838–846. <a href="https://doi.org/10.1016/j.jvs.2005.07.034">https://doi.org/10.1016/j.jvs.2005.07.034</a>
</div>
<div id="ref-olin2011" class="csl-entry">
78. Olin, J. W., &amp; Sealove, B. A. (2011). Diagnosis, management, and future developments of fibromuscular dysplasia. <em>Journal of Vascular Surgery</em>, <em>53</em>(3), 826–836.e1. <a href="https://doi.org/10.1016/j.jvs.2010.10.066">https://doi.org/10.1016/j.jvs.2010.10.066</a>
</div>
<div id="ref-lather2017" class="csl-entry">
79. Lather, H. D., Gornik, H. L., Olin, J. W., Gu, X., Heidt, S. T., Kim, E. S. H., Kadian-Dodov, D., Sharma, A., Gray, B., Jaff, M. R., &amp; al., et. (2017). Prevalence of intracranial aneurysm in women with fibromuscular dysplasia. <em>JAMA Neurology</em>, <em>74</em>(9), 1081–1087. <a href="https://doi.org/10.1001/jamaneurol.2017.1333">https://doi.org/10.1001/jamaneurol.2017.1333</a>
</div>
<div id="ref-robertson2019" class="csl-entry">
80. Robertson, V., Poli, F., Hobson, B., Saratzis, A., &amp; Ross Naylor, A. (2019). A systematic review and meta-analysis of the presentation and surgical management of patients with carotid body tumours. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>57</em>(4), 477–486. <a href="https://doi.org/10.1016/j.ejvs.2018.10.038">https://doi.org/10.1016/j.ejvs.2018.10.038</a>
</div>
<div id="ref-davila2016" class="csl-entry">
81. Davila, V. J., Chang, J. M., Stone, W. M., Fowl, R. J., Bower, T. C., Hinni, M. L., &amp; Money, S. R. (2016). Current surgical management of carotid body tumors. <em>Journal of Vascular Surgery</em>, <em>64</em>(6), 1703–1710. <a href="https://doi.org/10.1016/j.jvs.2016.05.076">https://doi.org/10.1016/j.jvs.2016.05.076</a>
</div>
<div id="ref-power2012" class="csl-entry">
82. Power, A. H., Bower, T. C., Kasperbauer, J., Link, M. J., Oderich, G., Cloft, H., Young, W. F., &amp; Gloviczki, P. (2012). Impact of preoperative embolization on outcomes of carotid body tumor resections. <em>Journal of Vascular Surgery</em>, <em>56</em>(4), 979–989. <a href="https://doi.org/10.1016/j.jvs.2012.03.037">https://doi.org/10.1016/j.jvs.2012.03.037</a>
</div>
<div id="ref-kruger2010" class="csl-entry">
83. Kruger, A. J., Walker, P. J., Foster, W. J., Jenkins, J. S., Boyne, N. S., &amp; Jenkins, J. (2010). Important observations made managing carotid body tumors during a 25-year experience. <em>Journal of Vascular Surgery</em>, <em>52</em>(6), 1518–1523. <a href="https://doi.org/10.1016/j.jvs.2010.06.153">https://doi.org/10.1016/j.jvs.2010.06.153</a>
</div>
<div id="ref-sugawara" class="csl-entry">
84. Sugawara, Y., Kikuchi, T., Ueda, T., Nishizaki, M., Nakata, S., Mochizuki, T., &amp; Ikezoe, J. (n.d.). <em>Usefulness of brain SPECT to evaluate brain tolerance and hemodynamic changes during temporary balloon occlusion test and after permanent carotid occlusion</em>. 8.
</div>
<div id="ref-tansavatdi2015" class="csl-entry">
85. Tansavatdi, K., Dublin, A. B., Donald, P. J., &amp; Dahlin, B. (2015). Combined balloon test occlusion and SPECT analysis for carotid sacrifice: Angiographic predictors for success or failure? <em>Journal of Neurological Surgery. Part B, Skull Base</em>, <em>76</em>(4), 249–251. <a href="https://doi.org/10.1055/s-0035-1547363">https://doi.org/10.1055/s-0035-1547363</a>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="index.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="upper-extremity-and-thoracic-outlet.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": false,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": false,
"email": true
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/adam-mdmph/VS-Exam-Prep/blob/main/01-cerebrovascular.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["_main.pdf"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true
},
"info": false
});
});
</script>

</body>

</html>
